Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1050.Time spend outdoors in summer,46753,0.00262823535150917,0.0415127231352728,-0.0787367019936255,0.0839931726966439,0.949519129653147
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1060.Time spent outdoors in winter,44952,0.00671987246121132,0.0459477707759162,-0.0833377582595844,0.096777503182007,0.883725717716782
LYZL2,Lysozyme-like protein 2,Physical activities,X1070.Time spent watching television (TV),47768,-0.0224013573930064,0.0424595705475578,-0.10562211566622,0.0608194008802069,0.597788397008242
LYZL2,Lysozyme-like protein 2,Physical activities,X1080.Time spent using computer,44981,-0.0452200845774382,0.0410532963409793,-0.125684545405758,0.0352443762508813,0.270697184406533
LYZL2,Lysozyme-like protein 2,Physical activities,X1090.Time spent driving,41500,-0.00937505424636223,0.0473859226942483,-0.102251462727089,0.0835013542343645,0.843169830209757
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1160.Sleep duration,48428,0.0408292706275911,0.0373014240131172,-0.0322815204381186,0.113940061693301,0.273715823370849
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,34602,-0.00681211700805917,0.0166174251865736,-0.0393822703737433,0.025758036357625,0.681867535823304
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,34602,0.00377803246357473,0.0159590976169265,-0.0275017988656012,0.0350578637927507,0.81287351048057
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,34602,0.0209986954592301,0.0172496028143633,-0.0128105260569221,0.0548079169753822,0.223526587161054
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,34602,0.0329849439495502,0.0174635478046525,-0.00124360974756865,0.067213497646669,0.0589736699236283
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,34602,0.0201921190324367,0.0175154012012456,-0.0141380673220047,0.0545223053868781,0.249034892670058
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,34602,-0.0659512555342593,0.0454630464871289,-0.155058826649032,0.0231563155805133,0.146933581884272
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,34602,-0.0389840620238914,0.0458392685134298,-0.128829028310214,0.0508609042624309,0.395111917963406
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,34602,0.0225592224779426,0.0309837913211336,-0.0381690085114792,0.0832874534673645,0.466585398051329
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,34602,0.00287688118479194,0.0221073023740905,-0.0404534314684255,0.0462071938380094,0.896466342199651
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,34602,-0.00463093441353417,0.014237302579584,-0.0325360474695188,0.0232741786424505,0.744991070610682
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,34602,-0.0230887898778329,0.0216037691036763,-0.0654321773210385,0.0192545975653727,0.28523500874797
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,34602,-0.0123707007064677,0.0115795055927588,-0.0350665316682751,0.0103251302553396,0.285420630416036
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,34602,0.00789495517714502,0.0149438645288865,-0.0213950192994724,0.0371849296537625,0.59730762956236
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,34602,-0.0105638601770689,0.0214733623349039,-0.0526516503534805,0.0315239299993426,0.62277335523821
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,34602,0.00727727979281328,0.0202294160142308,-0.0323723755950791,0.0469269351807056,0.719057483205679
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,34602,-0.00720991475026769,0.0313089791688992,-0.0685755139213102,0.0541556844207748,0.817880850227171
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,34602,-0.02582258107216,0.0300062915323182,-0.0846349124755038,0.0329897503311837,0.389511838520568
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,34602,-0.00205294004945934,0.0155949303446375,-0.0326190035249489,0.0285131234260302,0.895272754490763
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,34602,0.00938717366903972,0.014877057413045,-0.0197718588605285,0.038546206198608,0.528078157778625
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,34602,0.019351187596595,0.0188539441044341,-0.0176025428480958,0.0563049180412858,0.304761494101858
LYZL2,Lysozyme-like protein 2,Health and medical history,X120040.Fatigue severity over the past week,34609,0.0686938347071908,0.0697751311907723,-0.0680654224267229,0.205453091841104,0.324912197455445
LYZL2,Lysozyme-like protein 2,Health and medical history,X120041.Waking unrefreshed severity over the past week,34607,0.0499433993200218,0.0702214398094526,-0.0876906227065054,0.187577421346549,0.476974101569376
LYZL2,Lysozyme-like protein 2,Health and medical history,X120042.Cognitive symptoms severity over the past week,34607,0.0719004224118543,0.0758859016682304,-0.0768359448578774,0.220636789681586,0.343436229169906
LYZL2,Lysozyme-like protein 2,Health and medical history,X120098.Mobility problems today,34611,0.0132523103882677,0.0792752382215573,-0.142127156525985,0.16863177730252,0.867243833985989
LYZL2,Lysozyme-like protein 2,Health and medical history,X120099.Self-care problems today,34611,0.208409664416206,0.115463431624403,-0.0178986615676239,0.434717990400036,0.0711326993156507
LYZL2,Lysozyme-like protein 2,Health and medical history,X120100.Problems doing usual activities,34611,0.075983423808228,0.0766204285688355,-0.0741926161866896,0.226159463803146,0.321394929569734
LYZL2,Lysozyme-like protein 2,Health and medical history,X120101.Pain or discomfort today,34611,-0.0758211444671322,0.0705849127289954,-0.214167573415963,0.0625252844816987,0.282788344062012
LYZL2,Lysozyme-like protein 2,Health and medical history,X120102.Anxiety or depression today,34611,0.0122699779378452,0.089451727410969,-0.163055407787654,0.187595363663344,0.890902544487607
LYZL2,Lysozyme-like protein 2,Health and medical history,X120103.Scale to indicate how health is today,34593,-0.00258269350288815,0.00505567627015638,-0.0124918189923946,0.00732643198661836,0.609476804743419
LYZL2,Lysozyme-like protein 2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,34589,0.0350992365361396,0.0917648155255895,-0.144759801894016,0.214958274966295,0.702112110438019
LYZL2,Lysozyme-like protein 2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",34578,-0.135237968867526,0.0982173196653883,-0.327743915411687,0.0572679776766348,0.168592435248521
LYZL2,Lysozyme-like protein 2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",34593,-0.0130715092669478,0.0707539676918462,-0.151749285942966,0.125606267409071,0.853435241929816
LYZL2,Lysozyme-like protein 2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,34594,0.0947139099659015,0.0731274854243316,-0.0486159614657883,0.238043781397591,0.195310449915757
LYZL2,Lysozyme-like protein 2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,34603,0.0187099246117962,0.107084087256667,-0.191174886411272,0.228594735634864,0.861304778058819
LYZL2,Lysozyme-like protein 2,Health and medical history,X120109.Feeling bad about self over the last two weeks,34587,-0.0461227674495783,0.104017278737299,-0.249996633774684,0.157751098875528,0.657483758845068
LYZL2,Lysozyme-like protein 2,Health and medical history,X120110.Trouble concentrating over the last two weeks,34598,0.141071143663821,0.0993229924503257,-0.0536019215388172,0.33574420886646,0.15557016924724
LYZL2,Lysozyme-like protein 2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,34596,0.0243173821154907,0.144961608341814,-0.259807370234464,0.308442134465446,0.866785848469301
LYZL2,Lysozyme-like protein 2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,34575,-0.197615414630932,0.22410724743997,-0.636865619613274,0.241634790351409,0.377930058861563
LYZL2,Lysozyme-like protein 2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",32772,-0.114470748736208,0.102509616334895,-0.315389596752602,0.0864480992801862,0.264204901389187
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,46904,-0.0960740893648992,0.0954994435153929,-0.283252998655069,0.0911048199252708,0.314421008538241
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,45436,-0.0186890901079442,0.0574584800253791,-0.131307710957687,0.0939295307417988,0.744986583170434
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X1289.Cooked vegetable intake,48047,-0.0417246011434798,0.0392896545652717,-0.118732324091412,0.0352831218044527,0.288260982514798
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,47373,-0.0588837848493686,0.0409274005162373,-0.139101489861194,0.0213339201624565,0.150242134495749
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X1309.Fresh fruit intake,47997,-0.0343445410442584,0.0401438424257086,-0.113026472198647,0.0443373901101304,0.392264852365819
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X1319.Dried fruit intake,46978,-0.0246250161444815,0.0404706812421765,-0.103947551379148,0.0546975190901844,0.54288650578638
LYZL2,Lysozyme-like protein 2,Health and medical history,X134.Number of self-reported cancers,48607,0.180214745888665,0.059650782685215,0.0632992118256433,0.297130279951686,0.00252133507154245
LYZL2,Lysozyme-like protein 2,Health and medical history,X135.Number of self-reported non-cancer illnesses,48608,-0.0188494093363945,0.0397806790531643,-0.0968195402805965,0.0591207216078074,0.635624134539532
LYZL2,Lysozyme-like protein 2,Health and medical history,"X136.Number of operations, self-reported",48608,0.0270705692228001,0.0388165351601621,-0.0490098396911176,0.103150978136718,0.485562181365795
LYZL2,Lysozyme-like protein 2,Health and medical history,X137.Number of treatments or medications taken,48608,0.043444064083266,0.0386789696312439,-0.032366716393972,0.119254844560504,0.261368149795958
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X1438.Bread intake,48083,0.00407693407007495,0.00281617733783599,-0.00144277351208359,0.0095966416522335,0.147722122952548
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X1458.Cereal intake,47799,0.0703010456278195,0.0386697902100008,-0.00549174318378204,0.146093834439421,0.0690827099863291
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X1488.Tea intake,48007,-0.000513035135305028,0.00271691471256312,-0.00583818797192874,0.00481211770131868,0.850228057535306
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X1498.Coffee intake,47173,-0.0184503136949334,0.0384489759933921,-0.093810306641982,0.0569096792521151,0.631329304888717
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X1528.Water intake,47069,-0.0829259289649265,0.0385625009466996,-0.158508430820458,-0.00734342710939535,0.0315346482764148
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1568.Average weekly red wine intake,42440,0.0241283805236594,0.0449272180102109,-0.0639289667763539,0.112185727823673,0.591238745256453
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,42441,-0.0580523554133884,0.0460669149224777,-0.148343508661445,0.032238797834668,0.207628588659809
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1588.Average weekly beer plus cider intake,42481,-0.0331586755599554,0.0513507077890182,-0.133806062826431,0.0674887117065203,0.518465594427592
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1598.Average weekly spirits intake,42427,0.0482483374019982,0.0482075801606922,-0.0462385197129585,0.142735194516955,0.316919832983093
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1608.Average weekly fortified wine intake,42469,0.167842247420954,0.0696634125461764,0.0313019588304487,0.30438253601146,0.0159953036179501
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1737.Childhood sunburn occasions,43338,0.0455735392189099,0.0467489950605489,-0.046054491099766,0.137201569537586,0.329648358088286
LYZL2,Lysozyme-like protein 2,Health and medical history,X1807.Father's age at death,46849,-0.000747368007071015,0.00263015123846208,-0.00590246443445669,0.00440772842031466,0.776295694534581
LYZL2,Lysozyme-like protein 2,Health and medical history,X1845.Mother's age,32072,0.0055828615230873,0.0121800016708525,-0.0182899417517835,0.0294556647979581,0.646726311504261
LYZL2,Lysozyme-like protein 2,Health and medical history,X1873.Number of full brothers,48263,-0.0186572854154523,0.0372307671231943,-0.0916295889769131,0.0543150181460085,0.616288612289111
LYZL2,Lysozyme-like protein 2,Health and medical history,X1883.Number of full sisters,48267,0.0462696509688224,0.0371962071613321,-0.0266349150673885,0.119174217005033,0.213538903434449
LYZL2,Lysozyme-like protein 2,Physical measures,X20015.Sitting height,48471,-0.00650682822871421,0.00350370059520559,-0.0133740813953172,0.000360424937888752,0.0633078719573907
LYZL2,Lysozyme-like protein 2,Cognitive function,X20016.Fluid intelligence score,35623,0.0527868817739235,0.0592741435095956,-0.063390439504884,0.168964203052731,0.373201364867778
LYZL2,Lysozyme-like protein 2,Cognitive function,X20018.Prospective memory result,35908,0.00606174169417863,0.0730858596162242,-0.137186543153621,0.149310026541978,0.933901715657848
LYZL2,Lysozyme-like protein 2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),35508,-0.00712384496558822,0.00476238280358726,-0.0164581152606193,0.0022104253294428,0.134740830966
LYZL2,Lysozyme-like protein 2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),35493,-0.00658935113714199,0.00478651945573678,-0.0159709292703861,0.00279222699610209,0.168670114930998
LYZL2,Lysozyme-like protein 2,Cognitive function,X20023.Mean time to correctly identify matches,48358,0.00511315830787901,0.00286182397308364,-0.00049601667936493,0.0107223332951229,0.0740053273365523
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#1.Illnesses of father_Heart disease,45760,-0.00475287510804241,0.00598657231860441,-0.0164865568525071,0.00698080663642223,0.427251859260184
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,45398,-0.00779953919852285,0.0125095607467256,-0.032318278262105,0.0167191998650593,0.532973806803635
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,45362,-0.0208240891957634,0.0171374069400707,-0.0544134067983019,0.0127652284067752,0.224336217761371
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#12.Illnesses of father_Severe depression,45374,0.0117522238294434,0.0159839958682975,-0.0195764080724198,0.0430808557313066,0.462198257863033
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,45398,0.0103034417137188,0.0111217273094006,-0.0114951438127065,0.032102027240144,0.354239164979088
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#2.Illnesses of father_Stroke,45536,0.0133385949610283,0.00753959146133002,-0.00143900430317851,0.0281161942252352,0.0768891151565203
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,45496,0.00252284774391222,0.00916450532554706,-0.01543958269416,0.0204852781819845,0.783101036835312
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,45403,0.00278429422611076,0.0118040907670902,-0.020351723677386,0.0259203121296075,0.813532364432705
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,45543,-0.00393392368271099,0.00811666104462592,-0.0198425793301778,0.0119747319647558,0.627915057721754
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,45539,-0.0127754450809343,0.00753098964790623,-0.0275361847908305,0.00198529462896188,0.0898323557375821
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#9.Illnesses of father_Diabetes,45429,0.0177945735139285,0.010832370357458,-0.00343687238668923,0.0390260194145462,0.100459822859673
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,46665,0.00977895519555338,0.0064952079233129,-0.00295165233413991,0.0225095627252467,0.132197056946169
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,46532,0.00310713827539888,0.00850294867712132,-0.0135586411317589,0.0197729176825567,0.714803181978665
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,46457,-0.00553141423082229,0.0188421945678992,-0.0424621155839047,0.0313992871222602,0.769093634525589
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,46476,-0.00610154970230472,0.0118176547426395,-0.0292641529978782,0.0170610535932688,0.605645914593551
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#2.Illnesses of mother_Stroke,46615,-0.007771319093607,0.00710129063146753,-0.0216898487312834,0.00614721054406936,0.273815295303758
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,46495,-0.0298985191382358,0.0136537772896424,-0.0566599226259348,-0.00313711565053677,0.0285548269706178
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,46481,-0.00177973882003123,0.0115780075866073,-0.0244726336897816,0.0209131560497191,0.877834522594433
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,46486,-0.0120718333046926,0.0101708301176053,-0.032006660335199,0.00786299372581387,0.235280462242507
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,46529,0.0228141961551169,0.011282297815061,0.000700892437597377,0.0449274998726364,0.0431789542642196
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,46651,0.0021787686666578,0.00631453823073835,-0.0101977262655894,0.014555263598905,0.730068409371777
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,46543,-0.00576120026729821,0.00971114084172339,-0.0247950363170761,0.0132726357824796,0.553017043668785
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,43531,-0.00610194385483268,0.00822944185285273,-0.022231649886424,0.0100277621767587,0.458416270236021
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,43372,0.00554638339149219,0.028811660390627,-0.0509244709741368,0.0620172377571212,0.847349552726856
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,43366,0.0393673788071222,0.0305896852346401,-0.0205884042527724,0.0993231618670169,0.19813292485155
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,43394,-0.0133033396723855,0.0126364742102956,-0.0380708291245649,0.0114641497797939,0.292462926709869
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,43388,0.00666559726395102,0.0172119595681526,-0.0270698434896281,0.0404010380175302,0.698565507193447
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,43417,0.0114115712584679,0.0136456186590585,-0.0153338413132868,0.0381569838302225,0.403010903550608
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,43386,0.0119035017225468,0.015422371992639,-0.0183243473830257,0.0421313508281193,0.440225961790309
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,43380,-0.0224098187955554,0.0156443649173293,-0.0530727740335208,0.00825313644241003,0.152036229597706
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,43400,-0.00395488363841464,0.0125700516481619,-0.0285921848688119,0.0206824175919826,0.753049134742139
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,43416,-0.0177443362552319,0.0149938913681734,-0.0471323633368517,0.011643690826388,0.236655505821414
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,43558,0.00179976870579074,0.00693558710638278,-0.0117939820227195,0.015393519434301,0.795254997144354
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,43470,-0.0146628330672159,0.00951144605090534,-0.0333052673269904,0.00397960119255858,0.123193300830547
LYZL2,Lysozyme-like protein 2,Mental health,X20127.Neuroticism score,44447,0.0436800509623537,0.0394569584145185,-0.0336555875301025,0.12101568945481,0.268298271852448
LYZL2,Lysozyme-like protein 2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,35623,0.0711561827654272,0.0591733042028516,-0.044823493472162,0.187135859003016,0.229212366581701
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X20161.Pack years of smoking,35781,-0.00477324007096298,0.00460151224393388,-0.0137922040690734,0.00424572392714743,0.299624881077618
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,35781,-0.00558730808038739,0.00475610832459643,-0.0149092803965964,0.00373466423582161,0.240131332980715
LYZL2,Lysozyme-like protein 2,Cognitive function,X20191.Fluid intelligence score,33514,-0.0925176607849829,0.0742224954643099,-0.23799375189503,0.0529584303250646,0.212652022073583
LYZL2,Lysozyme-like protein 2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,33515,-0.110689246721681,0.076343059865499,-0.260321644058059,0.038943150614697,0.147161215869568
LYZL2,Lysozyme-like protein 2,Cognitive function,X20240.Maximum digits remembered correctly,32982,0.0763122273013547,0.0794598162040259,-0.0794290124585359,0.232053467061245,0.336921570301398
LYZL2,Lysozyme-like protein 2,Physical measures,X20255.Spirometry QC measure,43552,-0.0143604692513344,0.0495614076095492,-0.111500828166051,0.082779889663382,0.772010891786936
LYZL2,Lysozyme-like protein 2,Eye measures,X20261.avMSE,33586,-0.00022164091855757,0.00527661637914573,-0.0105638090216832,0.0101205271845681,0.966497128030055
LYZL2,Lysozyme-like protein 2,Eye measures,X20262.Myopia diagnosis,33586,-0.00693235305469252,0.0957740361904111,-0.194649463987898,0.180784757878513,0.942300900253381
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X20280.Glucose-lactate,40055,0.00878189147646697,0.00358049592557006,0.00176411946234965,0.0157996634905843,0.0141943669750009
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X20281.Spectrometer-corrected alanine,40075,0.0123747315157207,0.0036682842463418,0.00518489439289077,0.0195645686385506,0.000744946225660716
LYZL2,Lysozyme-like protein 2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,35259,-0.00591680707724603,0.0215095164195655,-0.0480754592595944,0.0362418451051023,0.783265243346719
LYZL2,Lysozyme-like protein 2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,35259,-0.0187164634941519,0.0406889592045359,-0.0984668235350423,0.0610338965467385,0.645540784396062
LYZL2,Lysozyme-like protein 2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),35259,-0.0190418805574266,0.0647526913922956,-0.145957155686326,0.107873394571473,0.768713809638684
LYZL2,Lysozyme-like protein 2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),35259,-0.00895683870399136,0.0198366616923645,-0.0478366956210258,0.0299230182130431,0.651624085481701
LYZL2,Lysozyme-like protein 2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),35259,-0.039715752427345,0.0413543043578747,-0.120770188968779,0.0413386841140894,0.336903432740268
LYZL2,Lysozyme-like protein 2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,35263,-0.0501502198836805,0.0508529593833979,-0.14982202027514,0.0495215805077793,0.324083638474099
LYZL2,Lysozyme-like protein 2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,35263,-0.010139699942212,0.0325465531949122,-0.0739309442042398,0.0536515443198159,0.755397412806136
LYZL2,Lysozyme-like protein 2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,35263,-0.0267320337390111,0.0381912602402873,-0.101586903809974,0.0481228363319519,0.483984359188689
LYZL2,Lysozyme-like protein 2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,35263,0.0213615063776513,0.0593774583124912,-0.0950183119148314,0.137741324670134,0.719040748406459
LYZL2,Lysozyme-like protein 2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,35263,-0.0304476195682662,0.0679545913874854,-0.163638618687738,0.102743379551205,0.65412710633215
LYZL2,Lysozyme-like protein 2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,35263,-0.0183282631006448,0.0419223232484441,-0.100496016667595,0.0638394904663057,0.661984920490909
LYZL2,Lysozyme-like protein 2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,35263,-0.0808195127707139,0.0703893214511406,-0.21878258281495,0.0571435572735217,0.250940094504954
LYZL2,Lysozyme-like protein 2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,35263,0.00795167248641278,0.0494859134887653,-0.0890407179515673,0.104944062924393,0.872346398952554
LYZL2,Lysozyme-like protein 2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),35262,-0.118755799391037,0.070355938190848,-0.256653438245099,0.019141839463025,0.0914763270630771
LYZL2,Lysozyme-like protein 2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),35262,-0.00819363901370333,0.0267908881806855,-0.060703779847847,0.0443165018204403,0.759739413346104
LYZL2,Lysozyme-like protein 2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),35262,-0.0356749979684241,0.0508438236479452,-0.135328892318397,0.0639788963815486,0.482919106578282
LYZL2,Lysozyme-like protein 2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,35263,-0.0164648368250348,0.0887256965080085,-0.190367201980732,0.157437528330662,0.852788100377469
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20600.Liking for adding salt to foods,35148,-0.0205619300801422,0.0632826497030025,-0.144595923498027,0.103472063337743,0.745251479456656
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20601.Liking for aniseed,35148,-0.00240683492639012,0.0629158981315525,-0.125721995264233,0.120908325411453,0.969485815422587
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20602.Liking for apple juice,35148,0.0848149846659491,0.0623719238207629,-0.0374339860227463,0.207063955354644,0.173936453185331
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20603.Liking for apples,35148,0.0265285658896683,0.0635349046060054,-0.0979998471381024,0.151056978917439,0.676296228423377
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20604.Liking for asparagus,35148,0.0621347476059464,0.062749000800497,-0.0608532939630278,0.185122789174921,0.322111321700451
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20605.Liking for aubergine,35148,-0.0336017505723963,0.0628150068095706,-0.156719163919155,0.089515662774362,0.592716959258674
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20606.Liking for avocados,35148,0.0190497062012573,0.0617405167153471,-0.101961706560823,0.140061118963338,0.757678740304481
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20607.Liking for bacon,35148,-0.00332225602809276,0.0634988897451967,-0.127780079928678,0.121135567872493,0.958275549108588
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20608.Liking for baked or steamed fish,35148,0.114126980216789,0.0635241423901017,-0.0103803388678098,0.238634299301389,0.0724511253274642
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20609.Liking for bananas,35148,0.124035134989917,0.0651888459849599,-0.00373500314060421,0.251805273120438,0.0571273328808135
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,35148,0.015066792428685,0.0617238244577266,-0.105911903508459,0.136045488365829,0.807161709567277
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20611.Liking for beef steak,35148,0.097275437445033,0.0622547693515507,-0.0247439104840065,0.219294785374072,0.118214547836581
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20612.Liking for beetroot,35148,0.0614222374672361,0.0622833600657431,-0.0606531482616204,0.183497623196093,0.324087812665415
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20613.Liking for bell pepper,35148,-0.0549167400168743,0.0613236030356846,-0.175111001966816,0.0652775219330676,0.370543458173222
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20614.Liking for bicycling,35148,0.00180876564161151,0.0616404648937531,-0.119006545550145,0.122624076833368,0.976591377376384
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20615.Liking for biscuits,35148,0.0286009617966008,0.0612376854133383,-0.0914249016135423,0.148626825206744,0.640482380567907
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20616.Liking for bitter foods,35148,-0.0673066551257488,0.0616133045868546,-0.188068732115984,0.0534554218644861,0.274699583636915
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20617.Liking for bitter or ale,35148,0.0658056657446236,0.0633483973410579,-0.05835719304385,0.189968524533097,0.298944776445705
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20618.Liking for black olives,35148,0.0253096283058876,0.0623773011854024,-0.0969498820175011,0.147569138629276,0.684940450462736
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20619.Liking for black pepper,35148,-0.064223972391255,0.0624906428805802,-0.186705632437192,0.0582576876546821,0.304115170779
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20620.Liking for blue cheese,35148,0.0324114792732293,0.0634928263036505,-0.0920344602819256,0.156857418828384,0.609737912059303
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20621.Liking for bolognese sauce,35148,-0.0747585353590199,0.0618508994278147,-0.195986298237537,0.046469227519497,0.226830211895806
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20622.Liking for broad beans,35148,0.0731471146986973,0.0627750012236998,-0.0498918876997544,0.196186117097149,0.243973944703707
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20623.Liking for broccoli,35148,0.0649782836560253,0.0637961361405954,-0.0600621431795417,0.190018710491592,0.30846756012652
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20624.Liking for brown rice,35148,-0.0383378517357337,0.0623160984047668,-0.160477404609077,0.0838017011376092,0.538435726945154
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20625.Liking for brussel sprouts,35148,0.0347767773039764,0.0616886357784428,-0.0861329488217716,0.155686503429724,0.572947656689894
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20626.Liking for burgers (meat),35148,0.0616007270435129,0.0615003331364109,-0.0589399259038523,0.182141379990878,0.316561926854066
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20627.Liking for burn of spicy foods,35148,-0.0793882606815772,0.0617852307469586,-0.200487312945616,0.0417107915824615,0.198874927108582
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20628.Liking for butter on bread,35148,0.125209630375661,0.0624407428935707,0.00282577430426198,0.247593486447059,0.0449810060603562
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20629.Liking for butternut squash,35148,-0.0763835900676471,0.0616752540216283,-0.197267087950039,0.0444999078147444,0.215586904356556
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20630.Liking for cabbage,35148,0.085771929287188,0.0625651473865779,-0.0368557595905047,0.208399618164881,0.170451061506924
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20631.Liking for cake,35148,0.00300871239336462,0.0617664660325464,-0.118053561030426,0.124070985817156,0.96115116757184
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20632.Liking for cake icing,35148,-0.000394889441213723,0.0614129143881825,-0.120764201642051,0.119974422759624,0.994869796186757
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20633.Liking for capers,35148,-0.0282156901395363,0.0610617036028477,-0.147896629201118,0.0914652489220453,0.644037359843894
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20634.Liking for cauliflower,35148,0.15090188096934,0.0637444959770854,0.0259626688542528,0.275841093084428,0.0179505971718747
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20635.Liking for cereal or granola bar,35148,0.0202047798353106,0.0618360649392024,-0.100993907445526,0.141403467116147,0.743870370786242
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20636.Liking for cheesecake,35148,0.0531509122834134,0.061539575572264,-0.0674666558382241,0.173768480405051,0.3877948709803
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20637.Liking for cherries,35148,0.0754606657732396,0.0666637976361568,-0.0552003775936278,0.206121709140107,0.257697452914305
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20638.Liking for chicken,35148,0.0193370434940541,0.0650154840144572,-0.108093305174282,0.14676739216239,0.766154645178209
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20639.Liking for chilli pepper,35148,-0.0691684537609116,0.0626694286873685,-0.192000533988154,0.0536636264663306,0.269766545846248
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20640.Liking for chips or french fries,35148,0.0720567438033774,0.0615394460722039,-0.0485605704981423,0.192674058104897,0.24168455699668
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20641.Liking for cigarette smoking,35148,0.0669703182254738,0.108580387527807,-0.145847241329028,0.279787877779976,0.537402815014214
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20642.Liking for cod,35148,0.153619169194776,0.0651336677587758,0.0259571803875755,0.281281158001977,0.0183800723455803
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20643.Liking for coffee with sugar,35148,0.0703673670131323,0.0676558915836416,-0.0622381804908052,0.20297291451707,0.29834621707781
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20644.Liking for coffee without sugar,35148,-0.0394865806770431,0.0626549794034776,-0.162290340307859,0.083317178953773,0.528573212060725
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20645.Liking for coriander,35148,-0.0992450003650949,0.0615184914387438,-0.219821243585033,0.0213312428548429,0.106742241749344
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20646.Liking for corn flakes,35148,0.163128296296237,0.0625992199444969,0.0404338252050234,0.285822767387451,0.00918574875605295
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20647.Liking for cream,35148,0.062633192537046,0.0618627545310187,-0.0586178063437507,0.183884191417843,0.311362239461139
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20648.Liking for croissant,35148,0.0458182665049009,0.0626660136394742,-0.0770071202284685,0.16864365323827,0.46471624865607
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20649.Liking for cucumber,35148,-0.00343439252406213,0.0615223705658097,-0.124018238833049,0.117149453784925,0.955484309543962
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20650.Liking for curry,35148,-0.0535630884186884,0.0626555043954551,-0.17636787703378,0.0692417001964035,0.392650699872307
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20651.Liking for dairy products,35148,0.0498477257923771,0.0632279903953833,-0.0740791353825742,0.173774586967328,0.430505505524577
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20652.Liking for dark chocolate,35148,-0.00993175647422249,0.0622527914649167,-0.131947227745459,0.112083714797014,0.873249547916029
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20653.Liking for diet fizzy drinks,35148,-0.0204627280381546,0.0649221183707281,-0.147710080044782,0.106784623968472,0.752629330836352
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20654.Liking for dried fruit,35148,0.015607112724521,0.0622830307333599,-0.106467627512864,0.137681852961906,0.802144639156741
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20655.Liking for eggs,35148,-0.0209641262544432,0.0633629916630458,-0.145155589914013,0.103227337405127,0.74076372335622
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20656.Liking for exercising alone,35148,0.0122137732737944,0.0619720155024832,-0.109251377111073,0.133678923658662,0.843767523970556
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20657.Liking for exercising with others,35148,-0.017614812972129,0.0612571305048872,-0.137678788761708,0.10244916281745,0.773697182973835
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20658.Liking for extra virgin olive oil,35148,-0.0855925230578975,0.0623590654397315,-0.207816291319771,0.0366312452039764,0.169936141734871
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20659.Liking for fatty foods,35148,0.0282386386883076,0.0616751192287619,-0.0926445950000656,0.149121872376681,0.647068960321782
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20660.Liking for fresh tomatoes,35148,-0.0155165473627561,0.0681206877704799,-0.149033095392897,0.118000000667384,0.819824913659097
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20661.Liking for fried chicken,35148,0.16752942184464,0.0617436031579669,0.0465119596550247,0.288546884034255,0.00668070725706039
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20662.Liking for fried or battered fish,35148,0.117774109850004,0.061953051958039,-0.00365387198775252,0.23920209168776,0.0573474535310376
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20663.Liking for fruit,35148,0.054242385104147,0.0719289903229355,-0.0867384359288065,0.1952232061371,0.450812921872085
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20664.Liking for garlic,35148,-0.02673534118602,0.0620003935727204,-0.148256112588552,0.0947854302165119,0.666329542104144
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20665.Liking for gherkins,35148,-0.00933220562348211,0.0624863011609235,-0.131805355898892,0.113140944651928,0.881284088146907
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20666.Liking for globe artichoke,35148,0.0394407951250398,0.0620351051917307,-0.0821480110507523,0.161029601300832,0.524943079317609
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20667.Liking for goat's cheese,35148,-0.0498808954212698,0.0612982869064626,-0.170025537757936,0.0702637469153969,0.415826247644798
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20668.Liking for going to a cafe,35148,-0.0651179387795699,0.0619142484119716,-0.186469865667034,0.0562339881078944,0.292959769219559
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20669.Liking for going to the gym,35148,-0.059058949883867,0.0619579271862624,-0.180496487168941,0.0623785874012073,0.340522155624571
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20670.Liking for going to the pub,35148,-0.0088226935325931,0.0625361347585231,-0.131393517659298,0.113748130594112,0.88781031510677
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20671.Liking for grapefruit,35148,0.0841691541841216,0.0619313593456896,-0.0372163101334301,0.205554618501673,0.174175442326789
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20672.Liking for green olives,35148,-0.0127442223969404,0.0615988249155358,-0.133477919231391,0.10798947443751,0.836102325567136
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20673.Liking for haddock,35148,-0.0085885614172001,0.0640680482094889,-0.134161935907798,0.116984813073398,0.893364617896479
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20674.Liking for ham,35148,0.0871396410356026,0.0617062748207198,-0.0338046576130082,0.208083939684214,0.157952772887675
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20675.Liking for hard cheese,35148,-0.00510242063207402,0.0636500240200277,-0.129856467711328,0.11965162644718,0.93610976865182
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20676.Liking for herring,35148,-0.0182713341169748,0.0618548909995347,-0.139506920476063,0.102964252242113,0.76770606662423
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20677.Liking for honey,35148,-0.047099401885686,0.0622078137006506,-0.169026716738961,0.0748279129675893,0.449001988982275
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20678.Liking for horseradish or wasabi,35148,-0.0441884564084466,0.0616259127190866,-0.164975245337856,0.0765983325209632,0.473375463360288
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20679.Liking for ice cream,35148,-0.0127125260808801,0.0622985746339116,-0.134817732363347,0.109392680201587,0.83831511518662
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20680.Liking for jam,35148,-0.0510576926441902,0.062633623776799,-0.173819595246716,0.0717042099583359,0.415001800758244
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20681.Liking for kiwi fruit,35148,0.200624130653119,0.0622349319915668,0.0786436639496477,0.32260459735659,0.00127248047565118
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20682.Liking for lager,35148,-0.0052224715926812,0.0627892903756424,-0.12828948072894,0.117844537543578,0.933715541181476
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20683.Liking for lamb,35148,0.0691570392950495,0.0628703981466002,-0.0540689410722868,0.192383019662386,0.271379424053309
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20684.Liking for lemons,35148,0.014200215105306,0.0630791881244275,-0.109434993618572,0.137835423829184,0.821895777682629
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20685.Liking for lentils or beans,35148,-0.0437954223603528,0.0636397505237442,-0.168529333386891,0.0809384886661858,0.491368079761039
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20686.Liking for liver,35148,0.14303520292513,0.0620636868437502,0.0213903767113793,0.26468002913888,0.0212203617091767
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20687.Liking for mackerel,35148,0.044513019489333,0.0619755024244428,-0.0769589652625749,0.165985004241241,0.47264018230248
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20688.Liking for marzipan,35148,0.112516169382031,0.0617904385288887,-0.00859309013459042,0.233625428898653,0.0686674801235212
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20689.Liking for mayonnaise,35148,-0.0271261988590405,0.061819608246756,-0.148292631022682,0.0940402333046012,0.660825280741201
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20690.Liking for melon,35148,0.150147393177881,0.0644896379156528,0.0237477028632015,0.276547083492561,0.0199327020075925
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20691.Liking for milk chocolate,35148,0.0224822403728688,0.0620206001831911,-0.0990781359861858,0.144042616731923,0.716994046093239
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20692.Liking for mushrooms,35148,0.00737723115806413,0.0632828436348117,-0.116657142366167,0.131411604682295,0.907200365851251
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20694.Liking for orange juice,35148,0.177990452911896,0.0619125024049037,0.0566419481982849,0.299338957625507,0.00405627773929888
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20695.Liking for oranges,35148,0.0717230111079993,0.0645352810518817,-0.0547661397536888,0.198212161969687,0.266451157959761
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20696.Liking for pasta,35148,-0.0105127713532228,0.0630683250402614,-0.134126688432135,0.11310114572569,0.867620737917918
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20697.Liking for pears,35148,0.0349545613258223,0.0633858511879358,-0.0892817070025318,0.159190829654176,0.581341269589775
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20698.Liking for pizza,35148,-0.0619327982228196,0.0626650055097253,-0.184756209021881,0.0608906125762419,0.323038362809802
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20699.Liking for plain yogurt,35148,-0.030248474124477,0.0615708542005932,-0.15092734835764,0.0904304001086857,0.623247192163438
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20700.Liking for plums,35148,0.00894662796500741,0.0633073316892205,-0.115135742145865,0.13302899807588,0.887621491343869
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20701.Liking for pollock,35148,0.0132741741279428,0.0610845780972881,-0.106451598942742,0.132999947198627,0.82797569563414
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20702.Liking for pork chop,35148,0.0825999708059179,0.0616986399160938,-0.0383293634296259,0.203529305041462,0.180698424793572
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20703.Liking for porridge,35148,0.0517213264668433,0.0636020851609899,-0.072938760448697,0.176381413382384,0.416134966285722
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20704.Liking for potato crisps,35148,0.00114368314714801,0.0616598815680727,-0.119709684726274,0.12199705102057,0.985202105460126
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20705.Liking for potatoes,35148,0.115289428350949,0.0625313202281716,-0.00727195929626701,0.237850815998165,0.0652755905344077
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20706.Liking for prawns,35148,0.024547028628759,0.0638020565119773,-0.100505002134717,0.149599059392235,0.700445846332933
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20707.Liking for raw carrots,35148,0.0160746096399495,0.0627745979112498,-0.1069636022661,0.139112821545999,0.79790665036338
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20708.Liking for red meat,35148,0.0860671483337681,0.062820793955802,-0.0370616078196039,0.20919590448714,0.170725417858822
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20709.Liking for red wine,35148,-0.00882398124979941,0.0627138822932515,-0.131743190544572,0.114095228044974,0.888109973413407
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,35148,-0.0178080894261523,0.065619698682862,-0.146422698844562,0.110806519992257,0.786105678650331
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20711.Liking for roast chicken,35148,0.0465500632618549,0.0643788059812655,-0.0796323964614255,0.172732522985135,0.46966837808086
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20712.Liking for salad dressing,35148,0.0742252118874032,0.0621900813265963,-0.0476673475127255,0.196117771287532,0.232712741902658
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20713.Liking for salad leaves,35148,-0.0130956163249836,0.0632283621184367,-0.13702320607712,0.110831973427152,0.835926225963189
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20714.Liking for salami,35148,-0.027814875937312,0.0618207647009105,-0.148983574751097,0.0933538228764725,0.652778961076665
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20715.Liking for salmon,35148,-0.00134627669662692,0.0656182317364832,-0.129958010900134,0.12726545750688,0.983631792156375
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20716.Liking for salty foods,35148,-0.0188905192379914,0.0616429630668384,-0.139710726848995,0.101929688373012,0.759272365407949
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20717.Liking for salty pretzels,35148,-0.10237230102958,0.061913569666451,-0.223722897575824,0.0189782955166639,0.09828781138027
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20718.Liking for sardines,35148,0.0660450759585274,0.0620965081678537,-0.0556640800504658,0.187754231967521,0.287558761728042
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20719.Liking for sausages (meat),35148,-0.0130455665302227,0.061525469366815,-0.13363548648918,0.107544353428735,0.832086824959247
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20720.Liking for savoury biscuits,35148,0.0116150463503593,0.0622751813430428,-0.110444309082005,0.133674401782723,0.85204991364101
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),35148,0.0229133026678916,0.0623661069481884,-0.0993242669505577,0.145150872286341,0.713333809498075
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20722.Liking for skimmed milk,35148,-0.0367125055282821,0.0621231709214901,-0.158473920534403,0.0850489094778386,0.554567569890559
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20723.Liking for smoked fish,35148,-0.0691045850423951,0.0620965668887555,-0.190813856144356,0.0526046860595657,0.265814943330208
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20724.Liking for soft cheese,35148,0.0532929063951785,0.0622231270861705,-0.0686644226937157,0.175250235484073,0.391766473670429
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20725.Liking for soy sauce,35148,-0.125305051075125,0.0618784169595946,-0.24658674831593,-0.00402335383431904,0.0429098823972751
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20726.Liking for soya milk,35148,0.00736267919592312,0.0627806089321854,-0.11568731431116,0.130412672703007,0.906645045855939
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20727.Liking for spicy foods,35148,-0.0808775414997591,0.061566095401856,-0.201547088487397,0.0397920054878787,0.189007924042415
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20728.Liking for spinach,35148,0.00503243077574632,0.0631608011759489,-0.118762739529114,0.128827601080606,0.936497242120273
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20729.Liking for spirits,35148,0.0734431651261039,0.0619408105233094,-0.0479608234995825,0.19484715375179,0.235788527006539
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20730.Liking for strawberries,35148,-0.0558672403860072,0.0675431709483114,-0.188251855444698,0.0765173746726833,0.408194419879609
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,35148,0.0871864646839538,0.063578511088357,-0.037427417049226,0.211800346417134,0.170327074646232
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20732.Liking for sweet foods,35148,-0.0179951236642488,0.0617666898265152,-0.139057835724219,0.103067588395721,0.770801260928358
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20733.Liking for taking the stairs,35148,-0.00201883958503129,0.0630972389968567,-0.12568942801887,0.121651748848808,0.974476563528988
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20734.Liking for tea with sugar,35148,0.108825554243721,0.0748890960356001,-0.037957073986055,0.255608182473497,0.146233170673517
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20735.Liking for tea without sugar,35148,-0.0761284509983488,0.0653198145265357,-0.204155287470359,0.0518983854736613,0.243874522200751
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20736.Liking for tomato ketchup,35148,0.0731435672757779,0.0623383566117953,-0.0490396116833409,0.195326746234897,0.240709838326774
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20737.Liking for tinned tuna,35148,0.00906590296531314,0.0620097961555858,-0.112473297499635,0.130605103430261,0.883767561608031
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20738.Liking for turnip (white),35148,0.0841136987275943,0.0613296199670367,-0.0360923564077976,0.204319753862986,0.170270268923975
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20739.Liking for vegetables,35148,0.0789200228193226,0.0692789341613484,-0.0568666881369203,0.214706733775566,0.254680926476431
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20740.Liking for vinegar,35148,-0.0186169728488186,0.0626739318876265,-0.141457879348566,0.104223933650929,0.766442595401432
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20741.Liking for watching television,35148,-0.0264310863282993,0.063139971671051,-0.150185430803559,0.0973232581469607,0.675515574916593
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20742.Liking for whisky,35148,0.0451321603636312,0.0631583397885745,-0.0786581856219748,0.168922506349237,0.474892026001219
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20743.Liking for white bread,35148,0.0244735482217949,0.0623980287686164,-0.0978265881646933,0.146773684608283,0.694912174183741
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20744.Liking for white rice,35148,0.0472772788268754,0.0621762400206947,-0.0745881516136861,0.169142709267437,0.447060421371494
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20745.Liking for white wine,35148,-0.0611219601758064,0.0623058245815511,-0.183241376355647,0.0609974560040338,0.326633086248805
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,35148,0.0459083376011637,0.0626689090182885,-0.0769227240746818,0.168739399277009,0.463859593605647
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20747.Liking for whole milk,35148,0.123907045071963,0.0625815785313927,0.00124715115043304,0.246566938993493,0.0477576146169979
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20748.Liking for wholemeal bread,35148,0.05097644814858,0.0661053456344903,-0.0785900292950209,0.180542925592181,0.440654852109483
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20749.Liking for working up a sweat,35148,-0.00257525585823938,0.0621660455101483,-0.12442070505813,0.119270193341651,0.966958122216673
LYZL2,Lysozyme-like protein 2,Physical measures,X21001.Body mass index (BMI),48522,0.00794661570282085,0.0123133465666501,-0.0161875435678133,0.032080774973455,0.518697666640893
LYZL2,Lysozyme-like protein 2,Physical measures,X21002.Weight,48534,-0.0217315304673661,0.00661181402283365,-0.03469068595212,-0.00877237498261211,0.00101523112860938
LYZL2,Lysozyme-like protein 2,Physical measures,X21021.Pulse wave Arterial Stiffness index,35874,-0.00590209171195205,0.00452560191378069,-0.0147722714629622,0.00296808803905809,0.192225271406386
LYZL2,Lysozyme-like protein 2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,34965,-0.0017047281452676,0.068933343781184,-0.136814081956388,0.133404625665853,0.980271105786719
LYZL2,Lysozyme-like protein 2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,34979,-0.0150967579642573,0.0691120285957833,-0.150556334011993,0.120362818083478,0.82709484079779
LYZL2,Lysozyme-like protein 2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,34981,0.00916683140193334,0.0688732036354354,-0.12582464772352,0.144158310527387,0.894121129945339
LYZL2,Lysozyme-like protein 2,Health and medical history,X21040.Satisfaction with bowel habits,34938,-0.0127255518588355,0.0629757236876454,-0.13615797028662,0.110706866568949,0.83986857980082
LYZL2,Lysozyme-like protein 2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,34919,0.0755626225819788,0.0685456692205318,-0.0587868890902636,0.209912134254221,0.270347683844146
LYZL2,Lysozyme-like protein 2,Health and medical history,X21042.Greatest number of times bowels opened per day,34940,0.0199779788974342,0.0686987763534151,-0.114671622755259,0.154627580550128,0.771210610532588
LYZL2,Lysozyme-like protein 2,Health and medical history,X21043.Least number of times bowels opened per week,34883,0.0450479568868048,0.0683320620560896,-0.0888828847431308,0.17897879851674,0.509761509595894
LYZL2,Lysozyme-like protein 2,Health and medical history,X21044.Average number of times bowels opened per day,34910,0.0122877872884073,0.0781369676561782,-0.140860669317702,0.165436243894517,0.875045830702804
LYZL2,Lysozyme-like protein 2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,34982,0.0759124291492606,0.0696078923271793,-0.0605190398120108,0.212343898110532,0.275506593357271
LYZL2,Lysozyme-like protein 2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,34978,0.144288373236733,0.0695216889026805,0.00802586298747909,0.280550883485987,0.0379895005385846
LYZL2,Lysozyme-like protein 2,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,32251,0.134756186135373,0.121066439903569,-0.102534036075622,0.372046408346368,0.265763200863127
LYZL2,Lysozyme-like protein 2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,34981,0.0998648945000438,0.0804522734775522,-0.0578215615159585,0.257551350516046,0.214547617986801
LYZL2,Lysozyme-like protein 2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,34980,0.0817773350044728,0.108595286817317,-0.131069427157468,0.294624097166414,0.451452424980539
LYZL2,Lysozyme-like protein 2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,34977,-0.09620648496691,0.0797199741808179,-0.252457634361313,0.0600446644274931,0.227556516319965
LYZL2,Lysozyme-like protein 2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,34977,-0.300617111818267,0.182517250607297,-0.65835092300857,0.0571166993720362,0.0995997744679823
LYZL2,Lysozyme-like protein 2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,34983,-0.016444015330972,0.0818185759884793,-0.176808424268391,0.143920393606448,0.840720147579505
LYZL2,Lysozyme-like protein 2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,34980,-0.0737222021110904,0.0752382402609654,-0.221189153022583,0.0737447488004018,0.327201060078961
LYZL2,Lysozyme-like protein 2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,34848,0.0432970872388084,0.0733600703081261,-0.100488650565119,0.187082825042735,0.555080407166779
LYZL2,Lysozyme-like protein 2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,34977,0.00130030187268773,0.0698919365753105,-0.135687893814921,0.138288497560296,0.985157285279559
LYZL2,Lysozyme-like protein 2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,34979,-0.0625792274818717,0.110245385757014,-0.278660183565619,0.153501728601875,0.570304325949949
LYZL2,Lysozyme-like protein 2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,34984,0.0745967099974962,0.0702108969888034,-0.0630166481005583,0.212210068095551,0.288068380772676
LYZL2,Lysozyme-like protein 2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,34983,-0.00915272039518816,0.06897318427833,-0.144340161580715,0.126034720790339,0.894435498331549
LYZL2,Lysozyme-like protein 2,Working and living environment,X21100.Water hardness (USGS classification),48490,-0.0218923052875069,0.0375134502216099,-0.0954186677218622,0.0516340571468484,0.559506045399901
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X2139.Age first had sexual intercourse,45328,0.00280023617029166,0.00300678139736907,-0.00309305536855173,0.00869352770913504,0.351708784565275
LYZL2,Lysozyme-like protein 2,Health and medical history,X2149.Lifetime number of sexual partners,44331,-0.0117848815714144,0.0429354086581467,-0.0959382825413818,0.0723685193985531,0.783720043365004
LYZL2,Lysozyme-like protein 2,Physical activities,X22032.IPAQ activity group,44329,-0.117321756578936,0.042086818367367,-0.199811920578975,-0.0348315925788967,0.00531641633084371
LYZL2,Lysozyme-like protein 2,Physical activities,X22033.Summed days activity,44749,-0.00376090156336488,0.0030032254613181,-0.00964722346754835,0.0021254203408186,0.210483967189656
LYZL2,Lysozyme-like protein 2,Physical activities,X22034.Summed minutes activity,44329,-0.00379775774045548,0.00297718708807647,-0.00963304443308536,0.00203752895217439,0.202109654710519
LYZL2,Lysozyme-like protein 2,Physical activities,X22037.MET minutes per week for walking,43497,-0.00290382259450569,0.00319633496491876,-0.00916863912574645,0.00336099393673508,0.363637305157649
LYZL2,Lysozyme-like protein 2,Physical activities,X22038.MET minutes per week for moderate activity,44329,-0.00105837120681698,0.00289967397355777,-0.0067417321949902,0.00462498978135624,0.715119027393547
LYZL2,Lysozyme-like protein 2,Physical activities,X22039.MET minutes per week for vigorous activity,44329,-0.109962626791301,0.0422163552415393,-0.192706683064718,-0.0272185705178843,0.00920339142949316
LYZL2,Lysozyme-like protein 2,Physical activities,X22040.Summed MET minutes per week for all activity,43497,-0.00434833704676105,0.00310252616068777,-0.0104292883217091,0.00173261422818699,0.161072183344064
LYZL2,Lysozyme-like protein 2,Eye measures,X2217.Age started wearing glasses or contact lenses,46936,0.00134620640336719,0.00251229420302911,-0.00357789023456986,0.00627030304130423,0.592070713291627
LYZL2,Lysozyme-like protein 2,Working and living environment,X22501.Year ended full time education,33356,0.00023660872460182,0.0127828297657519,-0.0248177376162719,0.0252909550654755,0.985232978094114
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X22506.Tobacco smoking,33333,0.202385159327568,0.167377000767526,-0.125673762176782,0.530444080831919,0.226671431960716
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,47503,0.202618157518831,0.13209261131872,-0.0562833606658592,0.461519675703522,0.125069112108266
LYZL2,Lysozyme-like protein 2,Physical measures,X23098.Weight,48128,-0.0213238510231763,0.00667473620471714,-0.0344063339844219,-0.0082413680619307,0.00140200427439458
LYZL2,Lysozyme-like protein 2,Physical measures,X23099.Body fat percentage,48120,0.0102528569930528,0.0063631959548744,-0.00221900707850106,0.0227247210646066,0.107136526229227
LYZL2,Lysozyme-like protein 2,Physical measures,X23100.Whole body fat mass,48107,-0.00500689828605127,0.00627354407185448,-0.017303044666886,0.00728924809478352,0.424824076457051
LYZL2,Lysozyme-like protein 2,Physical measures,X23101.Whole body fat-free mass,48127,-0.0194464582016941,0.00542896008172816,-0.0300872199618813,-0.00880569644150695,0.000341847026846587
LYZL2,Lysozyme-like protein 2,Physical measures,X23102.Whole body water mass,48128,-0.0202385273622373,0.00544510676465029,-0.0309109366209519,-0.00956611810352273,0.000202320246939363
LYZL2,Lysozyme-like protein 2,Physical measures,X23104.Body mass index (BMI),48128,0.0112551929140714,0.0122885544535248,-0.0128303738148373,0.03534075964298,0.359726491662932
LYZL2,Lysozyme-like protein 2,Physical measures,X23105.Basal metabolic rate,48128,-0.020715587649864,0.00579805947436263,-0.0320797842196148,-0.00935139108011328,0.0003539958717098
LYZL2,Lysozyme-like protein 2,Physical measures,X23106.Impedance of whole body,48125,0.00757293318615913,0.00444426545653838,-0.00113782710865611,0.0162836934809744,0.0884014980774391
LYZL2,Lysozyme-like protein 2,Physical measures,X23107.Impedance of leg (right),48128,0.0064727598977319,0.00360286571607189,-0.000588856905769004,0.0135343767012328,0.0724216326742736
LYZL2,Lysozyme-like protein 2,Physical measures,X23108.Impedance of leg (left),48128,0.00679616346564265,0.00356997553847565,-0.000200988589769617,0.0137933155210549,0.0569643751370895
LYZL2,Lysozyme-like protein 2,Physical measures,X23109.Impedance of arm (right),48126,0.000439267432894081,0.00438562125310995,-0.00815655022320142,0.00903508508898959,0.920217709048551
LYZL2,Lysozyme-like protein 2,Physical measures,X23110.Impedance of arm (left),48128,0.00184442517470695,0.00440093715521347,-0.00678141164951145,0.0104702619989253,0.675149064856432
LYZL2,Lysozyme-like protein 2,Physical measures,X23111.Leg fat percentage (right),48128,0.0138974616856851,0.00751216909394548,-0.00082638973844805,0.0286213131098182,0.0643301010123778
LYZL2,Lysozyme-like protein 2,Physical measures,X23112.Leg fat mass (right),48128,-0.00648627927666839,0.00823466552550817,-0.0226262237066644,0.00965366515332763,0.430893913983051
LYZL2,Lysozyme-like protein 2,Physical measures,X23113.Leg fat-free mass (right),48127,-0.0216019315864855,0.00553769835929097,-0.0324558203706958,-0.0107480428022752,9.61722989407088e-05
LYZL2,Lysozyme-like protein 2,Physical measures,X23114.Leg predicted mass (right),48127,-0.0214048525280109,0.00556814270035466,-0.032318412220706,-0.0104912928353157,0.000121359637521678
LYZL2,Lysozyme-like protein 2,Physical measures,X23115.Leg fat percentage (left),48125,0.0150771991175421,0.00786975303705374,-0.000347516835083278,0.0305019150701674,0.0554003245589914
LYZL2,Lysozyme-like protein 2,Physical measures,X23116.Leg fat mass (left),48125,-0.00875771470378955,0.00859278148063335,-0.0255995664058309,0.00808413699825182,0.308123712598378
LYZL2,Lysozyme-like protein 2,Physical measures,X23117.Leg fat-free mass (left),48124,-0.0210141205424148,0.00581405202048269,-0.0324096625025609,-0.00961857858226876,0.000301862483277709
LYZL2,Lysozyme-like protein 2,Physical measures,X23118.Leg predicted mass (left),48124,-0.0210511845631181,0.00584955668574195,-0.0325163156671723,-0.00958605345906389,0.000320546700410749
LYZL2,Lysozyme-like protein 2,Physical measures,X23119.Arm fat percentage (right),48124,0.0023428298718715,0.00716295560823515,-0.0116965631202694,0.0163822228640124,0.743614125301261
LYZL2,Lysozyme-like protein 2,Physical measures,X23120.Arm fat mass (right),48122,-0.0143190519264423,0.00716470155667161,-0.0283618669775186,-0.000276236875365904,0.0456707730707118
LYZL2,Lysozyme-like protein 2,Physical measures,X23121.Arm fat-free mass (right),48123,-0.0129726725649393,0.0055488396254873,-0.0238483982308944,-0.00209694689898423,0.01940241831839
LYZL2,Lysozyme-like protein 2,Physical measures,X23122.Arm predicted mass (right),48123,-0.0139824693240757,0.00556022855206554,-0.0248805172861242,-0.00308442136202727,0.011920602267761
LYZL2,Lysozyme-like protein 2,Physical measures,X23123.Arm fat percentage (left),48122,0.00224887513916495,0.00734551503308794,-0.0121483343256874,0.0166460846040173,0.759489069126666
LYZL2,Lysozyme-like protein 2,Physical measures,X23124.Arm fat mass (left),48122,-0.0101053374471571,0.00717510663929362,-0.0241685464601726,0.00395787156585838,0.159032496993089
LYZL2,Lysozyme-like protein 2,Physical measures,X23125.Arm fat-free mass (left),48122,-0.0139066299162096,0.00566769007376846,-0.0250153024607958,-0.00279795737162345,0.0141496928532678
LYZL2,Lysozyme-like protein 2,Physical measures,X23126.Arm predicted mass (left),48120,-0.0139381073023477,0.00567276761626313,-0.0250567318302235,-0.00281948277447197,0.0140183700271656
LYZL2,Lysozyme-like protein 2,Physical measures,X23127.Trunk fat percentage,48120,0.00570148094037415,0.00454730990978261,-0.00321124648279977,0.0146142083635481,0.209925097098368
LYZL2,Lysozyme-like protein 2,Physical measures,X23128.Trunk fat mass,48120,-0.00190401892609735,0.00508816521868094,-0.011876822754712,0.0080687849025173,0.708255695233522
LYZL2,Lysozyme-like protein 2,Physical measures,X23129.Trunk fat-free mass,48119,-0.0166204932416199,0.0049105860192524,-0.0262452418393546,-0.00699574464388517,0.000714201871286645
LYZL2,Lysozyme-like protein 2,Physical measures,X23130.Trunk predicted mass,48116,-0.0167462544549916,0.00493399401262661,-0.0264168827197398,-0.00707562619024348,0.000690067510348935
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23400.Total Cholesterol,40080,0.000517583355088926,0.00359595057370263,-0.00653047976936823,0.00756564647954608,0.885554415768014
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,40080,0.00369093469591324,0.00347867621194242,-0.0031272706794939,0.0105091400713204,0.288705701420705
LYZL2,Lysozyme-like protein 2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",40080,0.00360138815919574,0.00347236583663179,-0.00320444888060257,0.010407225198994,0.299685781519893
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23403.VLDL Cholesterol,40080,0.0110171095166489,0.00351881385802307,0.0041202343549237,0.0179139846783741,0.0017472341510919
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23404.Clinical LDL Cholesterol,40080,0.000729081881579359,0.00347536483882227,-0.00608263320251228,0.007540796965671,0.833838852177151
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23405.LDL Cholesterol,40080,0.00371533224632192,0.00349024248333846,-0.00312554302102146,0.0105562075136653,0.287129870413403
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23406.HDL Cholesterol,40080,-0.0119742762172033,0.00404581519959448,-0.0199040740084085,-0.00404447842599811,0.00308632581414172
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23407.Total Triglycerides,40080,0.0241739705659916,0.00378823176440988,0.0167490363077482,0.031598904824235,1.82686678653756e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23408.Triglycerides in VLDL,40080,0.0244162308574903,0.00377271047603538,0.0170217183244609,0.0318107433905196,1.01004313728576e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23409.Triglycerides in LDL,40080,0.0205219115354715,0.00377767590548926,0.0131176667607126,0.0279261563102305,5.67926572395985e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23410.Triglycerides in HDL,40080,0.0169541517152297,0.00370699210193218,0.00968844719544261,0.0242198562350168,4.8479906180369e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,40080,0.00511480850217402,0.00373375496154569,-0.00220335122245552,0.0124329682268036,0.17075159227022
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23412.Phospholipids in VLDL,40080,0.0173534827108738,0.00362830014071456,0.0102420144350732,0.0244649509866743,1.75126163381059e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23413.Phospholipids in LDL,40080,0.00380605331115365,0.00347160526916303,-0.00299829301640589,0.0106103996387132,0.272955070640877
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23414.Phospholipids in HDL,40080,-0.00475355882474027,0.00400140213455333,-0.0125963070084648,0.00308918935898425,0.234869854193493
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23415.Total Esterified Cholesterol,40080,-0.000222648760626266,0.00361551597321715,-0.00730906006813187,0.00686376254687934,0.950897270372471
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,40080,0.0078975209666205,0.00347849892858651,0.00107966306659093,0.0147153788666501,0.0232038783118561
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,40080,0.00559996801089017,0.00349382214739339,-0.00124792339800088,0.0124478594197812,0.109003412542126
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,40080,-0.0123869886489431,0.00402336173232125,-0.0202727776442927,-0.00450119965359341,0.00208377242005262
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23419.Total Free Cholesterol,40080,0.00233969420260856,0.00355086878271223,-0.00462000861150741,0.00929939701672453,0.509969082270263
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23420.Free Cholesterol in VLDL,40080,0.0150302286384544,0.00358850870404883,0.00799675157851865,0.0220637056983901,2.83100612700702e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23421.Free Cholesterol in LDL,40080,-0.00141018105739539,0.00349727326604835,-0.00826483665885016,0.00544447454405938,0.686792091872421
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23422.Free Cholesterol in HDL,40080,-0.00978066006999069,0.00408142874239879,-0.0177802604050923,-0.00178105973488907,0.016574617103058
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,40080,0.00915456654048147,0.0035880980135341,0.00212189443395463,0.0161872386470083,0.0107435782454648
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23424.Total Lipids in VLDL,40080,0.0200294661128193,0.00367446993805855,0.0128275050342245,0.027231427191414,5.11856260212299e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23425.Total Lipids in LDL,40080,0.00483950429330252,0.00348870167004693,-0.00199835097998947,0.0116773595665945,0.165411164880861
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23426.Total Lipids in HDL,40080,-0.00661528408228038,0.00403040066278629,-0.0145148693813415,0.00128430121678075,0.100754392970262
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,40080,0.00179498054444794,0.00380690224921747,-0.00566654786401831,0.00925650895291418,0.637288267875494
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23428.Concentration of VLDL Particles,40080,0.0144510218347613,0.00358035932017082,0.00743351756722647,0.0214685261022961,5.4697323525033e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23429.Concentration of LDL Particles,40080,0.00552403074865879,0.00345310992323112,-0.00124406470087421,0.0122921261981918,0.109688334956901
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23430.Concentration of HDL Particles,40080,0.000841860395654116,0.00381269799184189,-0.00663102766835599,0.00831474845966422,0.825248898167684
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,40080,0.0257100899061685,0.00384787251442186,0.0181682597779017,0.0332519200344353,2.47824357698655e-11
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23432.Average Diameter for LDL Particles,40080,-0.00693535962104472,0.0036590367551651,-0.0141070716611683,0.000236352419078877,0.0580651206007815
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23433.Average Diameter for HDL Particles,40080,-0.0214758137085976,0.0041327469649059,-0.0295759977598132,-0.0133756296573821,2.06753156551126e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23434.Phosphoglycerides,40070,0.00640883638083605,0.00380850592451442,-0.00105583523121222,0.0138735079928843,0.0924484870823007
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,40070,0.0252191233836211,0.00395004121059344,0.017477042610858,0.0329612041563842,1.78941789668983e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23436.Total Cholines,40070,0.00442712724606218,0.00381627472128602,-0.00305277120765842,0.0119070256997828,0.246047752938933
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23437.Phosphatidylcholines,40070,0.00418865653329595,0.00384500562823589,-0.00334755449804638,0.0117248675646383,0.276012283661374
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23438.Sphingomyelins,40070,-0.00250656050545707,0.00374132909703193,-0.00983956553563966,0.00482644452472552,0.502894162707123
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23439.Apolipoprotein B,40080,0.00520316627612884,0.00345366781025654,-0.00156602263197397,0.0119723551842316,0.131951861563513
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23440.Apolipoprotein A1,40080,-0.00282031951129453,0.00393352989158695,-0.010530038098805,0.0048893990762159,0.473392839739165
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,40080,0.00599054643249731,0.00353392445113589,-0.000935945491729034,0.0129170383567236,0.0900747950634097
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23442.Total Fatty Acids,40070,0.0171977800635245,0.00368984724395112,0.00996567946538033,0.0244298806616687,3.18667187720109e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23443.Degree of Unsaturation,40070,-0.0143340100899983,0.0037169450409746,-0.0216192223703085,-0.00704879780968811,0.000115734568978084
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23444.Omega-3 Fatty Acids,40070,0.00667458406751193,0.00369381258143495,-0.000565288592100577,0.0139144567271244,0.0707956129940056
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23445.Omega-6 Fatty Acids,40070,0.00925069082038864,0.00364185266617388,0.00211265959468782,0.0163887220460894,0.0110956869600582
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,40070,0.00960353270097129,0.00369182832922691,0.00236754917568654,0.016839516226256,0.00929984625750643
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,40070,0.0224254494226482,0.00376848310830082,0.0150392225303786,0.0298116763149178,2.75080633959903e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23448.Saturated Fatty Acids,40070,0.016210243433065,0.00369124185634639,0.00897540939462607,0.0234450774715039,1.13613603906007e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23449.Linoleic Acid,40070,0.00898550554920311,0.00356256525440746,0.0020028776505645,0.0159681334478417,0.0116764597002804
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23450.Docosahexaenoic Acid,40070,-0.00273944806450707,0.00369401743635998,-0.00997972223977264,0.00450082611075849,0.458351522260854
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,40070,-0.00191398318063238,0.00363644047968871,-0.00904140652082226,0.0052134401595575,0.598666721250633
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,40070,-0.0197936656966758,0.00394086154787645,-0.0275177543305136,-0.012069577062838,5.17655889380214e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,40070,-0.0196959095767279,0.00388137966371119,-0.0273034137176019,-0.012088405435854,3.95014612962753e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,40070,0.0254340227858304,0.00394103094710426,0.017709602129506,0.0331584434421547,1.13835388076778e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,40070,0.00456387243805079,0.00358134565744689,-0.00245556505054512,0.0115833099266467,0.202568154595184
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,40070,-0.0105148871014415,0.00378158871919346,-0.0179268009910607,-0.00310297321182237,0.00543606311555048
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,40070,-0.0120050155825291,0.00363487821150557,-0.01912937687708,-0.00488065428797819,0.000960580257933741
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,40070,-0.0239730881290922,0.00394028370171811,-0.0316960441844597,-0.0162501320737247,1.21088979068722e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,40070,-0.00344293842489418,0.00360479418604763,-0.0105083350295475,0.00362245817975917,0.339548427066653
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23460.Alanine,40075,0.0101854168140506,0.00358072972990489,0.00316718654343705,0.0172036470846642,0.00445629682441204
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23461.Glutamine,40041,-0.00927008851888876,0.00357844501649549,-0.0162838407512199,-0.0022563362865576,0.00959549772719463
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23462.Glycine,40066,0.00856158553112242,0.00379263310143389,0.00112802465231199,0.0159951464099328,0.024001274798219
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23463.Histidine,40064,0.0035358600214358,0.00352366820434633,-0.00337052965908301,0.0104422497019546,0.315661314259074
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),40073,0.00710295926522454,0.00372348258148898,-0.00019506659449387,0.0144009851249429,0.0564677142970147
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23465.Isoleucine,40077,0.0034776539291332,0.0036277806364523,-0.0036327961183133,0.0105881039765797,0.337772778963027
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23466.Leucine,40077,0.00838065055219062,0.00366119353134408,0.00120471123075622,0.015556589873625,0.0220955828260243
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23467.Valine,40073,0.00756105833787922,0.00376948881601239,0.000172860258494943,0.0149492564172635,0.044896140828835
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23468.Phenylalanine,40074,0.00271996539066512,0.00356718504997863,-0.00427171730729299,0.00971164808862322,0.445780382512617
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23469.Tyrosine,40066,0.00439591509239476,0.00362995412360743,-0.00271879498987579,0.0115106251746653,0.225917436301713
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23470.Glucose,40059,-0.00465116133783359,0.00354948473107807,-0.0116081514107466,0.00230582873507943,0.190096203323098
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23471.Lactate,40060,0.0264394525271561,0.00355541534628494,0.0194708384484376,0.0334080666058746,1.11270653769598e-13
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23472.Pyruvate,40043,0.0083692323682205,0.0035564748133691,0.00139854173401706,0.0153399230024239,0.0186284561414835
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23473.Citrate,40078,0.00194025788753055,0.00356092560092818,-0.00503915629028868,0.00891967206534978,0.585850935359105
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23474.3-Hydroxybutyrate,39898,0.00428920699059589,0.00374339470963261,-0.00304784664028403,0.0116262606214758,0.25190072980695
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23475.Acetate,40069,-0.0120673227005119,0.0035153914947956,-0.0189574900303113,-0.00517715537071252,0.000599804722575449
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23476.Acetoacetate,40079,-0.00489501586718033,0.00361165633959933,-0.011973862292795,0.00218383055843436,0.175337946287914
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23477.Acetone,40079,-0.00508069483877268,0.00356777467473414,-0.0120735332012516,0.00191214352370623,0.154460232870713
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23478.Creatinine,39830,0.0146284475580281,0.0041745263289304,0.00644637595332453,0.0228105191627317,0.000459834978982167
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23479.Albumin,40077,0.00844002610836307,0.00357528932784999,0.00143245902577709,0.015447593190949,0.0182602066580611
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23480.Glycoprotein Acetyls,40080,0.0185771962158407,0.00380292667195032,0.0111234599388181,0.0260309324928633,1.04915389847051e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,40080,0.0201351213573541,0.00380918320462515,0.0126691222762889,0.0276011204384194,1.27479102111368e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,40080,0.0197852372226294,0.00376015100082407,0.0124153412610142,0.0271551331842445,1.45347287606779e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,40080,0.0204919002430674,0.00381985950215308,0.0130049756188474,0.0279788248672875,8.28057890357642e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,40080,0.0203419855753679,0.00377583795710412,0.0129413431794438,0.027742627971292,7.29700138973327e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,40080,0.0205411346849235,0.0037281124558332,0.0132340342714904,0.0278482350983565,3.67426932748308e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,40080,0.0203352808591211,0.00381236588432818,0.0128630437258378,0.0278075179924043,9.79810077788154e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,40080,0.0192949412768574,0.00372924503602021,0.0119856210062578,0.026604261547457,2.33270621774788e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,40080,0.0231755390677306,0.00379310024697396,0.0157410625836616,0.0306100155517996,1.03089811476411e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,40080,0.022855261639298,0.00377427721177598,0.0154576783042171,0.0302528449743789,1.44572544915605e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,40080,0.0212164096745111,0.00376629469264888,0.0138344720769193,0.0285983472721029,1.81253855460912e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,40080,0.0190160828941716,0.00367927712858199,0.0118046997221509,0.0262274660661923,2.40253829072564e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,40080,0.0169529089215408,0.00362001010647104,0.00985768911285759,0.0240481287302241,2.85970527965037e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,40080,0.0205958669528222,0.00373938684976011,0.0132666687272924,0.027925065178352,3.71561454375757e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,40080,0.0242747770814716,0.00379612175443544,0.0168343784427781,0.031715175720165,1.6753616849914e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,40080,0.022877178012783,0.00374714271904701,0.0155327782834508,0.0302215777421151,1.06150680251789e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23496.Total Lipids in Large VLDL,40080,0.022644253369914,0.00372553750957985,0.0153421998511375,0.0299463068886905,1.25675181597279e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23497.Phospholipids in Large VLDL,40080,0.0224248331549117,0.00374425827122669,0.0150860869433074,0.029763579366516,2.17638477629702e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23498.Cholesterol in Large VLDL,40080,0.0194699076503888,0.00367277025977213,0.0122712779412354,0.0266685373595421,1.17326720760053e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,40080,0.0164459718448194,0.00360937455152919,0.00937159772382218,0.0235203459658166,5.258893766945e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,40080,0.0220728467007361,0.0037378109965939,0.0147467371474121,0.0293989562540602,3.62554439070094e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23501.Triglycerides in Large VLDL,40080,0.0236435588186543,0.00371674663773852,0.0163587354086868,0.0309283822286218,2.08002764530673e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,40080,0.0126834677135575,0.00352197310076813,0.00578040043605191,0.019586534991063,0.000318113562389422
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,40080,0.0161787960345896,0.0035586894362468,0.0092037647395459,0.0231538273296333,5.51916247578426e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,40080,0.0116494954933571,0.00350796580412074,0.00477388251728047,0.0185251084694338,0.000900328188338586
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,40080,0.00243898509131222,0.00344905098079523,-0.00432115483104643,0.00919912501367087,0.479490441115092
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,40080,-0.00232233996756303,0.00346213832981863,-0.00910813109400755,0.00446345115888148,0.502373666289225
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,40080,0.00846606197472394,0.00348426895049899,0.00163689483174593,0.015295229117702,0.0151233925683043
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,40080,0.0237395131913468,0.00368703747161626,0.0165129197469789,0.0309661066357147,1.25623916526902e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,40080,0.0184375268827088,0.00363051336716836,0.0113217206830588,0.0255533330823588,3.86743460516214e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23510.Total Lipids in Small VLDL,40080,0.0179753740424532,0.00361996500212607,0.0108802426382862,0.0250705054466203,6.95204240683697e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23511.Phospholipids in Small VLDL,40080,0.0127959865262411,0.00353976101079651,0.00585805494507991,0.0197339181074022,0.000301785665267573
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23512.Cholesterol in Small VLDL,40080,0.0099067436877894,0.00350451513008227,0.00303789403282815,0.0167755933427506,0.00470938474224814
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,40080,0.0108682657721728,0.00351997058086885,0.00396912343366982,0.0177674081106757,0.00202286406894098
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,40080,0.00803515818075962,0.00348214934528959,0.00121014546399203,0.0148601708975272,0.021044050572981
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23515.Triglycerides in Small VLDL,40080,0.0245853898921073,0.00375196350556748,0.0172315414211951,0.0319392383630196,5.90689016352775e-11
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,40080,0.0038855834030088,0.00354234758620889,-0.00305741786596063,0.0108285846719782,0.272711552117472
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,40080,0.00431077811587957,0.00357439111282023,-0.00269502846524809,0.0113165846970072,0.227836966255591
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,40080,0.00537644754980107,0.00357444127061808,-0.00162945734061036,0.0123823524402125,0.132575236472474
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,40080,-0.00326726865655739,0.00353258635092027,-0.0101911379043611,0.00365660059124634,0.355041440987817
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,40080,-0.00529230872546636,0.00353883075730844,-0.0122284170097909,0.00164379955885819,0.134813921477605
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,40080,0.001684032057065,0.00354676156987546,-0.00526762061989091,0.00863568473402091,0.634933096124624
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,40080,0.0198936419526572,0.0037535686582266,0.0125366473825331,0.0272506365227813,1.18113236691563e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23523.Concentration of IDL Particles,40080,-0.00205998868065633,0.00344514816605294,-0.00881247908612009,0.00469250172480743,0.549893029833408
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23524.Total Lipids in IDL,40080,-0.00338793594633348,0.0035509282860207,-0.010347755386934,0.00357188349426709,0.340054885471805
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23525.Phospholipids in IDL,40080,-0.00351972687977058,0.00355382066644701,-0.0104852153860067,0.00344576162646556,0.32199751120149
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23526.Cholesterol in IDL,40080,-0.00543532469764986,0.00355134516602791,-0.0123959612230646,0.00152531182776485,0.125922702589232
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,40080,-0.00490734447954965,0.00355650904155816,-0.0118781022010036,0.00206341324190433,0.167670223510245
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23528.Free Cholesterol in IDL,40080,-0.0068284197738901,0.00353334514610541,-0.0137537762602567,9.69367124764933e-05,0.0533156956273695
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23529.Triglycerides in IDL,40080,0.017043462690847,0.00376216251470489,0.00966962416202543,0.0244173012196686,5.95464537193538e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23530.Concentration of Large LDL Particles,40080,0.00436278203943604,0.00345294918144352,-0.00240499835619327,0.0111305624350653,0.206438606735512
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23531.Total Lipids in Large LDL,40080,0.00248231684492047,0.00351072681886523,-0.00439870772005538,0.00936334140989633,0.479540372681184
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23532.Phospholipids in Large LDL,40080,0.000934900211130588,0.00348721735060162,-0.00590004579604859,0.00776984621830977,0.788632449276125
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23533.Cholesterol in Large LDL,40080,0.00156828650001413,0.00351707945883549,-0.00532518923930342,0.00846176223933169,0.65567408453566
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,40080,0.00322945616963928,0.0035158026958866,-0.00366151711429846,0.010120429453577,0.358349023825552
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,40080,-0.00285832232141943,0.00352436199419828,-0.00976607183004805,0.0040494271872092,0.417372851830404
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23536.Triglycerides in Large LDL,40080,0.0184974515412288,0.0037697707275052,0.0111087009153187,0.025886202167139,9.39227672032609e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,40080,0.00701388846121303,0.00347440109428945,0.000204062316405709,0.0138237146060204,0.0435394387055624
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23538.Total Lipids in Medium LDL,40080,0.00887831726534799,0.00349615239084274,0.00202585857929623,0.0157307759513998,0.0111163638869602
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23539.Phospholipids in Medium LDL,40080,0.00861274891260725,0.00348679688818217,0.00177862701177019,0.0154468708134443,0.0135226141040543
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23540.Cholesterol in Medium LDL,40080,0.00761672361045353,0.00348853351446239,0.000779197922107252,0.0144542492987998,0.0290306089864924
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,40080,0.00969461333189367,0.00350626570532453,0.0028223325494576,0.0165668941143297,0.00570291580645795
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,40080,0.00176787103804899,0.00347849964977021,-0.00504998827550063,0.00858573035159861,0.611303731026718
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23543.Triglycerides in Medium LDL,40080,0.0227027766063223,0.00378480851858822,0.0152845519098894,0.0301210013027552,2.05612663620427e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23544.Concentration of Small LDL Particles,40080,0.00696566127341834,0.00345162466492105,0.00020047693017308,0.0137308456166636,0.0436072137125222
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23545.Total Lipids in Small LDL,40080,0.00768390487625379,0.00346070931452697,0.000900914619780923,0.0144668951327267,0.0264171192046656
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23546.Phospholipids in Small LDL,40080,0.00512326711345898,0.00343571149725635,-0.00161072742116345,0.0118572616480814,0.13594300100381
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23547.Cholesterol in Small LDL,40080,0.00650610269125832,0.00345850015399906,-0.000272557610579845,0.0132847629930965,0.0599724758757954
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,40080,0.00905632841420779,0.003479589772295,0.0022363324605096,0.015876324367906,0.00926182241209167
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,40080,-0.000345415460933354,0.00345066401404922,-0.00710871692846983,0.00641788600660312,0.920265859948505
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23550.Triglycerides in Small LDL,40080,0.0242508936553419,0.00379342344422353,0.0168157837046638,0.0316860036060201,1.69455507488612e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,40080,-0.017467116524319,0.00395119926855551,-0.0252114670906878,-0.00972276595795019,9.93289551353107e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,40080,-0.0205429458598676,0.00396748114300038,-0.0283192089001483,-0.0127666828195868,2.28487592886034e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,40080,-0.0208160979650741,0.00398822864154189,-0.0286330261024962,-0.012999169827652,1.82824614249531e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,40080,-0.0217020409523984,0.00393085074202928,-0.0294065084067758,-0.013997573498021,3.44899810810062e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,40080,-0.0216809318039022,0.00397685093830147,-0.029475559642973,-0.0138863039648313,5.09556701745243e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,40080,-0.0198449429815634,0.00374658261133581,-0.0271882448997816,-0.0125016410633452,1.20140318536952e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,40080,0.0133809546036214,0.00370094552196566,0.00612710138056866,0.0206348078266741,0.00030106423176583
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23558.Concentration of Large HDL Particles,40080,-0.0192761502421652,0.00416020121194757,-0.0274301446175825,-0.011122155866748,3.63767744569114e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23559.Total Lipids in Large HDL,40080,-0.0191793973474213,0.00416477612217574,-0.0273423585468857,-0.0110164361479568,4.16851135057752e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23560.Phospholipids in Large HDL,40080,-0.0175905836935731,0.00416004435031061,-0.0257442706201819,-0.00943689676696431,2.37218480895985e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23561.Cholesterol in Large HDL,40080,-0.021478560589247,0.00412495942045971,-0.029563481053348,-0.013393640125146,1.95445787690589e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,40080,-0.0217348150106544,0.00411769020288226,-0.0298054878083036,-0.0136641422130051,1.32824182402235e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,40080,-0.020017624581484,0.00412605950513839,-0.0281047012115552,-0.0119305479514128,1.24222674483707e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23564.Triglycerides in Large HDL,40080,0.00662920683415005,0.00380895512761053,-0.000836345215966597,0.0140947588842667,0.081812394003725
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,40080,-0.0027217782993593,0.00389623886532356,-0.0103584064753935,0.00491484987667487,0.484838493425935
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23566.Total Lipids in Medium HDL,40080,-0.000748793806359841,0.00386026090773332,-0.00831490518551714,0.00681731757279746,0.846199137998678
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23567.Phospholipids in Medium HDL,40080,0.00126623780291226,0.00383512319267139,-0.00625060365472367,0.00878307926054818,0.74127881680802
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23568.Cholesterol in Medium HDL,40080,-0.0055664971492342,0.00389013982008167,-0.0131911711965943,0.00205817689812588,0.152480502159784
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,40080,-0.0058631770150321,0.003868049781212,-0.0134445545862076,0.00171820055614343,0.129599806938937
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,40080,-0.00418808308722787,0.00396061651063166,-0.0119508914480659,0.00357472527361018,0.29033788614818
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23571.Triglycerides in Medium HDL,40080,0.0159615905545736,0.00368681803367408,0.00873542720857244,0.0231877539005748,1.50875423156843e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23572.Concentration of Small HDL Particles,40080,0.011271171941018,0.00355694698595817,0.00429955584854003,0.018242788033496,0.00153505278005509
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23573.Total Lipids in Small HDL,40080,0.0140815214482094,0.00358274295473923,0.0070593452569205,0.0211036976394983,8.5338518377238e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23574.Phospholipids in Small HDL,40080,0.0133370560665815,0.0036045570506188,0.00627212424736862,0.0204019878857943,0.000216615542507601
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23575.Cholesterol in Small HDL,40080,0.00956713697112426,0.00355672231248649,0.00259596123865074,0.0165383127035978,0.00715878749384089
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,40080,0.00822451842762787,0.00353010219368977,0.00130551812799593,0.0151435187272598,0.0198336190235594
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,40080,0.0116794259659326,0.00366117158472824,0.00450352965986523,0.0188553222719999,0.00142637316505983
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23578.Triglycerides in Small HDL,40080,0.0231499503075968,0.00375846864478088,0.0157833517638263,0.0305165488513673,7.55943550547206e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39665,-0.000143053183165364,0.00362126303286873,-0.00724072872758807,0.00695462236125734,0.968489579949159
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39665,-0.00844951539297033,0.00372457310104938,-0.0157496786710271,-0.00114935211491354,0.0233137641730243
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39665,-0.00475826183777617,0.00367964246038935,-0.0119703610601393,0.00245383738458696,0.195994085913677
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39665,-0.012308803258513,0.0037453225089217,-0.0196496353759996,-0.0049679711410265,0.00101793819016295
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39665,0.00592189171528905,0.00369542564961304,-0.00132114255795251,0.0131649259885306,0.109076918050384
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,39987,-0.00379416271156598,0.00358820857256638,-0.0108270515137961,0.00323872609066412,0.290353885708355
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,39987,-0.0189593192686072,0.00376131100505019,-0.0263314888385056,-0.0115871496987088,4.71564827510744e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,39987,-0.0177236229226949,0.00377086286327189,-0.0251145141347078,-0.010332731710682,2.63185741428127e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,39987,-0.0198204267772371,0.00370469081910223,-0.0270816207826774,-0.0125592327717967,8.97092061221201e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,39987,0.0175311448739443,0.00369551707316918,0.0102879314105327,0.0247743583373559,2.12335412812193e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,40079,0.013075365509984,0.00369347321177386,0.00583615801490718,0.0203145730050607,0.000401603682857178
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,40079,-0.0154044410830906,0.00358156011549416,-0.0224242989094592,-0.00838458325672206,1.71479373325772e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,40079,-0.0196420872332648,0.00367731921417275,-0.0268496328930434,-0.0124345415734862,9.40826687855074e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,40079,-0.0028580787567748,0.00353326148212618,-0.00978327126174212,0.00406711374819251,0.418586515574472
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,40079,0.00613538269031809,0.00352309588996925,-0.000769885254021638,0.0130406506346578,0.0816286377792623
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,40080,-0.0163163523666295,0.00357843089678184,-0.0233300769243219,-0.00930262780893712,5.18007477834691e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,40080,-0.0218905766316465,0.00371457399193842,-0.0291711416558458,-0.0146100116074472,3.90112569126625e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,40080,-0.0225694953525184,0.00375269390294791,-0.0299247754022963,-0.0152142153027405,1.86571204561703e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,40080,-0.0197847541956403,0.00362283335383296,-0.0268855075691529,-0.0126840008221277,4.83518593956905e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,40080,0.020813431837812,0.00367972200709309,0.0136011767039096,0.0280256869717145,1.58617290740785e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,40080,-0.0172359275632861,0.00371003172532078,-0.0245075897449148,-0.00996426538165735,3.42794985076936e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,40080,-0.0166985657131865,0.00361654028782333,-0.0237869846773202,-0.00961014674905279,3.93261746335066e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,40080,-0.014293264035056,0.00355109689471585,-0.0212534139486991,-0.00733311412141299,5.73544040065184e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,40080,-0.0181013768424366,0.00372371124979629,-0.0253998508920373,-0.0108029027928358,1.18358852943305e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,40080,0.0171409209275056,0.00364754581026501,0.00999173113938619,0.024290110715625,2.64250946915436e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,40080,0.0100776677546044,0.00363110654522078,0.00296069892597171,0.0171946365832372,0.00552328610555128
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,40080,-0.0223247735377657,0.00375500333446947,-0.0296845800733258,-0.0149649670022055,2.84350947524073e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,40080,-0.0227053201058322,0.00378559217352985,-0.0301250807659507,-0.0152855594457137,2.06332890401669e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,40080,-0.0151710438624164,0.00356175135650732,-0.0221520765211708,-0.00819001120366208,2.06667563554029e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,40080,0.02287308776514,0.0037382901613042,0.0155460390489838,0.0302001364812962,9.76497567267348e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,40080,0.000341994370861766,0.00344255544114287,-0.00640541429377826,0.00708940303550179,0.920867632340359
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,40080,-0.0149225843885272,0.00363739186026643,-0.0220518724346494,-0.00779329634240499,4.11596056756708e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,40080,-0.010578184639903,0.00364598461684124,-0.0177243144889119,-0.0034320547908942,0.00372333365061879
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,40080,-0.0162896933936092,0.00347728591404792,-0.0231051737851431,-0.00947421300207525,2.8390372604201e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,40080,0.0190450429924515,0.00374272434031463,0.0117093032854348,0.0263807826994682,3.66828800216545e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,40080,-0.0122319132025633,0.00347932933063749,-0.0190513986906128,-0.00541242771451384,0.000440554194920412
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,40080,-0.00923708101990804,0.00376153918952007,-0.0166096978313674,-0.0018644642084487,0.0140779247851381
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,40080,0.00939558217733705,0.00349117370071224,0.00255288172394105,0.016238282630733,0.00712959674407076
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,40080,-0.023719839644955,0.00375020681525875,-0.0310702450028622,-0.0163694342870479,2.63265809792906e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,40080,0.0150722998537667,0.00374958122555601,0.00772312065167691,0.0224214790558565,5.86578116112185e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,40080,-0.00384753415110657,0.00354604778385382,-0.0107977878074601,0.00310271950524691,0.277936651965007
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,40080,-0.00996101897419394,0.00346810483408231,-0.0167585044489953,-0.00316353349939261,0.00408439006400126
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,40080,0.0114068528939641,0.00358213383630467,0.00438587057480696,0.0184278352131213,0.0014547623946539
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,40080,-0.0226437995112462,0.00382947465024524,-0.0301495698257269,-0.0151380291967655,3.45960525917491e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,40080,0.0137819609186557,0.00368447348527205,0.00656039288752243,0.0210035289497889,0.000184559804417509
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,40080,-0.0126905638712181,0.00351648376103687,-0.0195828720428504,-0.00579825569958583,0.000308902811954955
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,40080,-0.004784019194803,0.00353641615439673,-0.0117153948574206,0.00214735646781459,0.176151656462761
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,40080,0.011445415386165,0.0035205690951136,0.00454509995974239,0.0183457308125877,0.00115344337470882
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,40080,-0.0184344009693199,0.00375116606536487,-0.0257866864574351,-0.0110821154812048,9.03928643265574e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,40080,0.0199579465471132,0.00375003066197437,0.0126078864496434,0.027308006644583,1.04628280856381e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,40072,-0.0188298140814074,0.0038973488269568,-0.0264686177822428,-0.0111910103805721,1.37398322742498e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,40072,0.00438004483329133,0.00369315624670055,-0.00285854141024175,0.0116186310768244,0.235652317752813
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,40072,-0.00260991135562639,0.003597493172174,-0.00966099797308742,0.00444117526183465,0.468172874181901
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,40072,0.0132785175082777,0.00410842901059376,0.00522599664751398,0.0213310383690415,0.00123285247276584
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,40072,0.0270083223170814,0.00389614709865012,0.0193718740037272,0.0346447706304357,4.38251660763051e-12
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,40080,0.0159460768193428,0.00380842259710035,0.00848156852902615,0.0234105851096595,2.84820937326897e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,40080,-0.021741245955654,0.00393701506080034,-0.0294577954748226,-0.0140246964364853,3.42337369495821e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,40080,-0.0207420554124511,0.00396101814967366,-0.0285056509858114,-0.0129784598390907,1.66660647745606e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,40080,-0.0160527870259203,0.0037252032165207,-0.0233541853303009,-0.00875138872153974,1.65257138613362e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,40080,0.0217612475835526,0.00389989362847267,0.0141174560717462,0.0294050390953591,2.46327668921042e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,40080,0.0149818462676074,0.00387096039284759,0.0073947638976261,0.0225689286375887,0.000109328194891485
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,40080,-0.0171585248015077,0.00383206355086265,-0.0246693693611985,-0.00964768024181686,7.62477757634255e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,40080,-0.0163119472131499,0.00379846243743272,-0.023756933590518,-0.00886696083578177,1.76720583193828e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,40080,-0.0128474663197235,0.00404910091716025,-0.0207837041173576,-0.00491122852208941,0.00151334514783082
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,40080,0.0176171005269158,0.0037749935665831,0.0102181131364129,0.0250160879174187,3.09592801416865e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,40080,-0.00451327564155714,0.0036733862680856,-0.0117131127270049,0.00268656144389064,0.219232724071208
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,40080,-0.00910059320836547,0.00367457547559087,-0.0163027611405236,-0.00189842527620737,0.0132777132880242
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,40080,-0.00792518263973873,0.00370775613572134,-0.0151923846657526,-0.000657980613724911,0.0325827606017329
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,40080,-0.00609796461237507,0.00369019025380186,-0.0133307375098267,0.00113480828507658,0.0984656313897417
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,40080,0.0194909727683008,0.00381061823185748,0.0120221610338601,0.0269597845027415,3.19231374938138e-07
LYZL2,Lysozyme-like protein 2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,48366,-0.000234366227973557,0.00300877666996718,-0.00613156850110924,0.00566283604516213,0.93791303226913
LYZL2,Lysozyme-like protein 2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,48366,-0.000824013488483491,0.00293655659188242,-0.00657966440857304,0.00493163743160606,0.7790161403792
LYZL2,Lysozyme-like protein 2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,47063,0.00159127188466127,0.00279175928181167,-0.00388057630768961,0.00706312007701214,0.568692372552939
LYZL2,Lysozyme-like protein 2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,47063,-0.00112393118970881,0.00307640941129292,-0.00715369363584292,0.0049058312564253,0.714862972297592
LYZL2,Lysozyme-like protein 2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,47063,0.00157488255806514,0.00298248686636105,-0.00427079170000251,0.0074205568161328,0.597475758507555
LYZL2,Lysozyme-like protein 2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,47063,0.00194551001285564,0.00274002879111453,-0.00342494641772884,0.00731596644344013,0.477693130275291
LYZL2,Lysozyme-like protein 2,Working and living environment,X24009.Traffic intensity on the nearest road,48366,0.0328554451718057,0.0814091023786701,-0.126706395490388,0.192417285833999,0.686522847433023
LYZL2,Lysozyme-like protein 2,Working and living environment,X24010.Inverse distance to the nearest road,48366,-0.00124055919823569,0.00264451184442544,-0.00642380241330955,0.00394268401683817,0.638998441348383
LYZL2,Lysozyme-like protein 2,Working and living environment,X24011.Traffic intensity on the nearest major road,48366,0.00231387491326875,0.00259932906916061,-0.00278081006228605,0.00740855988882356,0.373379552251799
LYZL2,Lysozyme-like protein 2,Working and living environment,X24012.Inverse distance to the nearest major road,48366,-0.0025456034491789,0.00266730975103962,-0.00777353056121655,0.00268232366285875,0.339907841862549
LYZL2,Lysozyme-like protein 2,Working and living environment,X24013.Total traffic load on major roads,48366,0.0238715874105264,0.0576557654530697,-0.0891337128774902,0.136876887698543,0.678852057803456
LYZL2,Lysozyme-like protein 2,Working and living environment,X24015.Sum of road length of major roads within 100m,48366,-0.0178673373098264,0.0566377541555658,-0.128877335454735,0.0931426608350826,0.752410604924868
LYZL2,Lysozyme-like protein 2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,48366,-0.00320060225291756,0.00299498474355308,-0.00907077235028159,0.00266956784444647,0.285239087353713
LYZL2,Lysozyme-like protein 2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,48366,-0.00377776473002633,0.00298897607942305,-0.0096361578456955,0.00208062838564285,0.206281545279655
LYZL2,Lysozyme-like protein 2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,48366,-0.00303884190208597,0.00295549045053188,-0.00883160318512846,0.00275391938095652,0.303867676497244
LYZL2,Lysozyme-like protein 2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,48318,-0.00214305499820647,0.00294404732643214,-0.00791338775801345,0.00362727776160051,0.466666466833554
LYZL2,Lysozyme-like protein 2,Working and living environment,X24020.Average daytime sound level of noise pollution,48366,-0.000113923090639505,0.00264935267470744,-0.00530665433306608,0.00507880815178707,0.965701703147279
LYZL2,Lysozyme-like protein 2,Working and living environment,X24021.Average evening sound level of noise pollution,48366,-0.000145689827988875,0.00265014564123531,-0.00533997528481009,0.00504859562883234,0.956159533384061
LYZL2,Lysozyme-like protein 2,Working and living environment,X24022.Average night-time sound level of noise pollution,48366,-0.0001305896308788,0.00264923143652806,-0.0053230832464738,0.0050619039847162,0.960685990843944
LYZL2,Lysozyme-like protein 2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,48366,-0.00013600129435312,0.00264969638423201,-0.00532940620744785,0.00505740361874161,0.959065389637209
LYZL2,Lysozyme-like protein 2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,48366,-0.000123637727955529,0.00264973075691606,-0.005317110011511,0.00506983455559994,0.962784308697458
LYZL2,Lysozyme-like protein 2,Health and medical history,X2405.Number of children fathered,38270,0.114772711600295,0.0658637925304756,-0.0143203217594374,0.243865744960027,0.081441448713589
LYZL2,Lysozyme-like protein 2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",46301,0.00219427843703238,0.0030679114591873,-0.00381882802297473,0.00820738489703949,0.474473448339438
LYZL2,Lysozyme-like protein 2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",46301,-0.000409575479667284,0.00275643007160185,-0.00581217842000691,0.00499302746067234,0.881879621229141
LYZL2,Lysozyme-like protein 2,Working and living environment,"X24502.Water percentage, buffer 1000m",46301,-0.00144236695283542,0.00279191164248463,-0.0069145137721053,0.00402977986643446,0.605425738920923
LYZL2,Lysozyme-like protein 2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",46301,0.00125061886444747,0.00286862817199477,-0.00437189235266228,0.00687313008155722,0.662868286580871
LYZL2,Lysozyme-like protein 2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",46301,0.000409180207418593,0.00276938827834795,-0.00501882081814338,0.00583718123298057,0.882540931246554
LYZL2,Lysozyme-like protein 2,Working and living environment,"X24505.Water percentage, buffer 300m",46301,-0.00128261147914458,0.00282600601093608,-0.0068215832605793,0.00425636030229014,0.649935253154966
LYZL2,Lysozyme-like protein 2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",48490,0.00118512469154681,0.00294481495453042,-0.00458671261933282,0.00695696200242645,0.687361356416719
LYZL2,Lysozyme-like protein 2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",48490,0.00173194925601863,0.00276554971149067,-0.00368852817850308,0.00715242669054034,0.531152752489103
LYZL2,Lysozyme-like protein 2,Working and living environment,X24508.Distance (Euclidean) to coast,48490,0.00329943772290185,0.00260233226367077,-0.00180113351389286,0.00840000895969656,0.204857108637027
LYZL2,Lysozyme-like protein 2,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,34545,0.0892141575031305,0.0770484118866559,-0.061800729794715,0.240229044800976,0.246957578059039
LYZL2,Lysozyme-like protein 2,Health and medical history,X2704.Years since last cervical smear test,37025,-0.054972396262679,0.0663087976205728,-0.184937639599002,0.0749928470736437,0.407109168829624
LYZL2,Lysozyme-like protein 2,Health and medical history,X2714.Age when periods started (menarche),39058,0.0279759481141688,0.05202596703455,-0.0739949472735493,0.129946843501887,0.59077526584298
LYZL2,Lysozyme-like protein 2,Health and medical history,X2734.Number of live births,39362,-0.0524311357372671,0.050261777112616,-0.150944218877995,0.0460819474034603,0.296898457445333
LYZL2,Lysozyme-like protein 2,Health and medical history,X2744.Birth weight of first child,37811,-0.10569707936913,0.0546554677134009,-0.212821796087396,0.0014276373491356,0.0531607025774704
LYZL2,Lysozyme-like protein 2,Health and medical history,X2754.Age at first live birth,36771,0.00299282931110212,0.00478474156221706,-0.00638526415084331,0.0123709227730475,0.531665423048988
LYZL2,Lysozyme-like protein 2,Health and medical history,X2764.Age at last live birth,36747,0.00606841892009286,0.0043908208807394,-0.00253759000615635,0.0146744278463421,0.166991276337483
LYZL2,Lysozyme-like protein 2,Health and medical history,X2794.Age started oral contraceptive pill,35846,0.00777853582329147,0.00658067969465935,-0.00511959637824085,0.0206766680248238,0.237237549882924
LYZL2,Lysozyme-like protein 2,Health and medical history,X2804.Age when last used oral contraceptive pill,35200,-0.00366355158597708,0.00500201396497357,-0.0134674989573253,0.00614039578537113,0.463943695253091
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X2867.Age started smoking in former smokers,35107,0.00119042110947628,0.00498302835576949,-0.00857631446783193,0.0109571566867845,0.81119519475751
LYZL2,Lysozyme-like protein 2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",34993,-0.075425057257454,0.0871941028846922,-0.246325498911451,0.0954753843965426,0.387060997388862
LYZL2,Lysozyme-like protein 2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,34991,0.0341922802563166,0.0938861616928193,-0.149824596661609,0.218209157174242,0.715730383069548
LYZL2,Lysozyme-like protein 2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,35003,0.0102589677287754,0.0993832385158685,-0.184532179762327,0.205050115219878,0.917786901700571
LYZL2,Lysozyme-like protein 2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",34978,-0.0120572923219544,0.0965859088436521,-0.201365673655512,0.177251089011604,0.900658596587675
LYZL2,Lysozyme-like protein 2,Mental health,X28739.Difficulty with standing for long periods,35004,0.0142488019506493,0.0746547646298109,-0.13207453672378,0.160572140625079,0.848639920083846
LYZL2,Lysozyme-like protein 2,Mental health,X28740.Difficulty with taking care of household responsibilities,35026,0.0380622902710844,0.0828677037970464,-0.124358409171127,0.200482989713295,0.646025877609719
LYZL2,Lysozyme-like protein 2,Mental health,X28741.Difficulty learning a new task,34970,0.10596245540942,0.092909260294709,-0.0761396947682093,0.28806460558705,0.254127855819291
LYZL2,Lysozyme-like protein 2,Mental health,X28742.Difficulty with joining in community activities,34754,0.0938819659895905,0.101063067007947,-0.104201645345986,0.291965577325167,0.35295827091016
LYZL2,Lysozyme-like protein 2,Mental health,X28743.Difficulty with being emotionally affected by health problems,34996,0.00539253068383986,0.0849999496084837,-0.161207370548788,0.171992431916468,0.949417068356591
LYZL2,Lysozyme-like protein 2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,35027,0.105358365189127,0.128011398268847,-0.145543975417814,0.356260705796067,0.410519514643371
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,34720,-0.111491093967086,0.0732826934981632,-0.255125173223485,0.0321429852893143,0.128220797351675
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X2897.Age stopped smoking,35104,0.00150415567446485,0.00469370880696033,-0.0076955135871774,0.0107038249361071,0.748629401358539
LYZL2,Lysozyme-like protein 2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,34417,-0.00981838166389177,0.011432028458174,-0.0322251574419128,0.0125883941141293,0.390463462200885
LYZL2,Lysozyme-like protein 2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,34417,0.0118677617448136,0.0127656419985176,-0.013152896572281,0.0368884200619081,0.352587883154626
LYZL2,Lysozyme-like protein 2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,34417,-0.0074040261597747,0.0434608673550537,-0.0925873261756799,0.0777792738561305,0.86473303263753
LYZL2,Lysozyme-like protein 2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,34417,-0.0273612498077685,0.0511270442354474,-0.127570256509245,0.0728477568937084,0.592560643230475
LYZL2,Lysozyme-like protein 2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,34417,0.110381151569562,0.0606777792944316,-0.00854729584752369,0.229309598986648,0.0689478689284063
LYZL2,Lysozyme-like protein 2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,34417,0.097005894901461,0.050089769250399,-0.00117005282932094,0.195181842632243,0.0528431279942759
LYZL2,Lysozyme-like protein 2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,34417,-0.0218060317134969,0.0209323344069849,-0.0628334071511873,0.0192213437241935,0.297580861272543
LYZL2,Lysozyme-like protein 2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,34417,0.0410477297156825,0.0362168240187409,-0.0299372453610497,0.112032704792415,0.257103187215643
LYZL2,Lysozyme-like protein 2,Mental health,X29002.Recent lack of interest or pleasure in doing things,34387,0.120018674853194,0.0958972979846649,-0.0679400291967489,0.307977378903138,0.210796317233435
LYZL2,Lysozyme-like protein 2,Mental health,X29003.Recent feelings of depression,34377,0.0906555233049776,0.0935850996423662,-0.0927712719940602,0.274082318604015,0.332742044351845
LYZL2,Lysozyme-like protein 2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",34390,0.0591435362478308,0.0731671552815764,-0.0842640881040589,0.202551160599721,0.418935064962378
LYZL2,Lysozyme-like protein 2,Mental health,X29005.Recent feelings of tiredness or low energy,34393,0.0842031183227425,0.0739707864102082,-0.0607796230412656,0.229185859686751,0.255035448603545
LYZL2,Lysozyme-like protein 2,Mental health,X29006.Recent poor appetite or overeating,34402,0.0493472217093914,0.114389559251296,-0.174856314423149,0.273550757841932,0.666198171964019
LYZL2,Lysozyme-like protein 2,Mental health,X29007.Recent feelings of inadequacy,34373,1.29207619529807e-05,0.107114426934363,-0.209931356029398,0.209957197553304,0.99990375919549
LYZL2,Lysozyme-like protein 2,Mental health,X29008.Recent trouble concentrating on things,34400,0.0807649539062367,0.103686972505281,-0.122461512204113,0.283991420016587,0.436056024952414
LYZL2,Lysozyme-like protein 2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,34395,-0.00113711041377457,0.181853360767487,-0.357569697518049,0.3552954766905,0.995011182089479
LYZL2,Lysozyme-like protein 2,Mental health,X29010.Recent thoughts of suicide or self-harm,34376,-0.0819214401711572,0.207599235726046,-0.488815942194207,0.324973061851892,0.693144469073171
LYZL2,Lysozyme-like protein 2,Mental health,X29038#0.Substances taken for depression_None of options listed,35206,0.019977185530001,0.0220399206382027,-0.0232210589208764,0.0631754299808783,0.364755661986737
LYZL2,Lysozyme-like protein 2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),35206,-0.045978980044345,0.0547542408145395,-0.153297292040842,0.0613393319521525,0.401091117380377
LYZL2,Lysozyme-like protein 2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),35206,-0.0127117801165025,0.0222861735376225,-0.0563926802502426,0.0309691200172376,0.568435451509914
LYZL2,Lysozyme-like protein 2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),35206,0.00639507906816239,0.0676978421044775,-0.126292691456614,0.139082849592938,0.924742903780068
LYZL2,Lysozyme-like protein 2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),35206,-0.0478645340290621,0.0553772597223658,-0.156403963084899,0.0606748950267748,0.387438072305129
LYZL2,Lysozyme-like protein 2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),35206,0.0375828202309641,0.0589588149618782,-0.0779764570943171,0.153142097556245,0.52386130408984
LYZL2,Lysozyme-like protein 2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),35206,0.0305439285941864,0.063382239169805,-0.0936852601786315,0.154773117367004,0.629894219120861
LYZL2,Lysozyme-like protein 2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),35206,-0.0124389259312284,0.061490114719588,-0.132959550781621,0.108081698919164,0.839695709917052
LYZL2,Lysozyme-like protein 2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),35206,0.0231691160979734,0.0393179406040065,-0.0538940474858793,0.100232279681826,0.5556983291007
LYZL2,Lysozyme-like protein 2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,35206,0.0101548052860219,0.0202013440506175,-0.0294398290531884,0.0497494396252322,0.615207906595717
LYZL2,Lysozyme-like protein 2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,35206,-0.0322805588949283,0.0352461544162489,-0.101363021550776,0.0368019037609195,0.359776825827609
LYZL2,Lysozyme-like protein 2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,35206,-0.0706423303771994,0.0567073143696356,-0.181788666541685,0.0405040057872864,0.212909958822497
LYZL2,Lysozyme-like protein 2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,35206,0.0212146043796464,0.0780718467524616,-0.131806215255178,0.174235424014471,0.78583756926399
LYZL2,Lysozyme-like protein 2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,35206,0.0539206925249161,0.0546967209011398,-0.053284880441318,0.16112626549115,0.324264969303265
LYZL2,Lysozyme-like protein 2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,35206,-0.0292420061958285,0.0762889045362466,-0.178768259086872,0.120284246695215,0.701506333428282
LYZL2,Lysozyme-like protein 2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,35206,0.0732937507090433,0.0716432685801683,-0.0671270557080866,0.213714557126173,0.30633127593262
LYZL2,Lysozyme-like protein 2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,35206,-0.039218427585946,0.0433252513368441,-0.12413592020616,0.0456990650342684,0.365390702115411
LYZL2,Lysozyme-like protein 2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,35206,0.0095958580758823,0.0418173594387976,-0.072366166424161,0.0915578825759256,0.818510909535707
LYZL2,Lysozyme-like protein 2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,35206,0.107898687468784,0.0605334926507006,-0.0107469581265893,0.226544333064157,0.0747242720932367
LYZL2,Lysozyme-like protein 2,Mental health,X29058.Recent feelings or nervousness or anxiety,34313,-0.0897122085813367,0.0888124945858206,-0.263784697969545,0.0843602808068716,0.312480538470099
LYZL2,Lysozyme-like protein 2,Mental health,X29059.Recent inability to stop or control worrying,34324,-0.0196050564354714,0.0905191708012053,-0.197022631205834,0.157812518334891,0.828540720535645
LYZL2,Lysozyme-like protein 2,Mental health,X29060.Recent worrying too much about different things,34322,0.0629476878978669,0.0825216462394189,-0.098794738731394,0.224690114527128,0.445616508595066
LYZL2,Lysozyme-like protein 2,Mental health,X29061.Recent trouble relaxing,34322,0.00643769928515984,0.0908844805098526,-0.171695882514151,0.184571281084471,0.943532740061991
LYZL2,Lysozyme-like protein 2,Mental health,X29062.Recent restlessness,34334,0.00116565841910436,0.13310151541013,-0.25971331178475,0.262044628622959,0.9930128240117
LYZL2,Lysozyme-like protein 2,Mental health,X29063.Recent easy annoyance or irritability,34306,-0.00856039277554771,0.0926704223286022,-0.190194420539608,0.173073634988513,0.926404044063536
LYZL2,Lysozyme-like protein 2,Mental health,X29064.Recent feelings of foreboding,34309,-0.0240769324001215,0.105595805250231,-0.231044710690574,0.18289084589033,0.819647341960196
LYZL2,Lysozyme-like protein 2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,35206,-0.0199927657861937,0.0253245941129184,-0.0696289702475137,0.0296434386751263,0.42987406260168
LYZL2,Lysozyme-like protein 2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,35206,0.0484990932946589,0.0433072037802834,-0.0363830261146967,0.133381212704014,0.26280745473001
LYZL2,Lysozyme-like protein 2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',35206,-0.0383248417008014,0.0547352508717612,-0.145605933409453,0.0689562500078506,0.483838414294836
LYZL2,Lysozyme-like protein 2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,35206,-0.0425201041042824,0.0523151041417579,-0.145057708222128,0.060017500013563,0.416382594353305
LYZL2,Lysozyme-like protein 2,Mental health,X29065#2.Symptoms of panic attack_Sweating,35206,-0.0488610640002689,0.0380111841101286,-0.123362984856121,0.0256408568555832,0.198688382709146
LYZL2,Lysozyme-like protein 2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,35206,0.0452571992845402,0.0418787091177511,-0.0368250705862519,0.127339469155332,0.279885849273015
LYZL2,Lysozyme-like protein 2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,35206,-0.0209580455073679,0.0415716021166707,-0.102438385656043,0.0605222946413068,0.614179141323843
LYZL2,Lysozyme-like protein 2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,35206,-0.000981130255093184,0.0424243330224777,-0.0841328229791494,0.0821705624689631,0.981550061239053
LYZL2,Lysozyme-like protein 2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,35206,0.00855141138247082,0.0513387596600066,-0.0920725575511421,0.109175380316084,0.867715317221519
LYZL2,Lysozyme-like protein 2,Mental health,X29076.Felt loved as a child,34307,0.0374902266953821,0.0777827564191195,-0.114963975886092,0.189944429276856,0.629836286685861
LYZL2,Lysozyme-like protein 2,Mental health,X29077.Physically abused by family as a child,34327,-0.0755923735445831,0.115821522504674,-0.302602557653744,0.151417810564577,0.514003077190411
LYZL2,Lysozyme-like protein 2,Mental health,X29078.Felt hated by family member as a child,34312,-0.0610734487373491,0.11701104266258,-0.290415092356006,0.168268194881308,0.601730511624956
LYZL2,Lysozyme-like protein 2,Mental health,X29079.Sexually molested as a child,34273,-0.0755013082848487,0.149262613916147,-0.368056031560496,0.217053414990799,0.612998900639073
LYZL2,Lysozyme-like protein 2,Mental health,X29080.Someone to take to doctor when needed as a child,34291,-0.152810901147421,0.10297779185061,-0.354647373174618,0.0490255708797749,0.137891766640812
LYZL2,Lysozyme-like protein 2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,34317,0.124232168385205,0.161545398427261,-0.192396812532227,0.440861149302637,0.441914963023836
LYZL2,Lysozyme-like protein 2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,34284,-0.0082833583127732,0.125907073148787,-0.255061221684396,0.23849450505885,0.947548032227762
LYZL2,Lysozyme-like protein 2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,34322,-0.149828528583666,0.149710215361017,-0.44326055069126,0.143603493523928,0.316975439341519
LYZL2,Lysozyme-like protein 2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,34309,-0.257927327060084,0.215683563894523,-0.680667112293348,0.164812458173181,0.231806677111108
LYZL2,Lysozyme-like protein 2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,34309,-0.163087055608049,0.192941312546687,-0.541252028199556,0.215077916983457,0.398000945993384
LYZL2,Lysozyme-like protein 2,Mental health,X29086.Experienced a violent or sexual assault,34323,-0.117125888781633,0.182664406393287,-0.475148125312475,0.24089634774921,0.521416172335775
LYZL2,Lysozyme-like protein 2,Mental health,X29087.Experienced a life-threatening injury or illness,34320,0.0722487056103156,0.0852890685389568,-0.0949178687260397,0.239415279946671,0.396976746702633
LYZL2,Lysozyme-like protein 2,Mental health,X29088.Experienced a marital separation or divorce,34321,-0.0712347213934134,0.0871116365862113,-0.241973529102387,0.0995040863155607,0.413543333674879
LYZL2,Lysozyme-like protein 2,Mental health,X29089.Experienced the death of a spouse or partner,34330,-0.0424781110337465,0.0962073022190322,-0.23104442338305,0.146088201315557,0.65885018912348
LYZL2,Lysozyme-like protein 2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,34321,-0.0794228813495628,0.112587343501236,-0.300094074611986,0.141248311912861,0.48057257030259
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29091.Frequency of drinking alcohol,34317,-0.0624962633563588,0.0690666549272252,-0.19786690701372,0.0728743803010026,0.365577456490739
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,33684,-0.0838986408718372,0.0887127996872957,-0.257775728258937,0.0899784465152624,0.344335603191463
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,33705,-0.0893263193233463,0.0915034150243467,-0.268673012771066,0.0900203741243733,0.329014032315976
LYZL2,Lysozyme-like protein 2,Mental health,X29104.Ever used cannabis,34319,-0.115922301456338,0.131824963797823,-0.374299230500071,0.142454627587394,0.379244482226915
LYZL2,Lysozyme-like protein 2,Mental health,X29108.Ever thought that life not worth living,34294,0.00656658147871974,0.0947861167498141,-0.179214207350916,0.192347370308355,0.944771147013548
LYZL2,Lysozyme-like protein 2,Mental health,X29109.Ever contemplated self-harm,34312,0.16516115435545,0.134616673661004,-0.0986875260201177,0.429009834731018,0.219916744257191
LYZL2,Lysozyme-like protein 2,Mental health,X29111.Ever self-harmed,34319,0.0213142023240586,0.247371902451316,-0.46353472648052,0.506163131128637,0.931340540203676
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,34306,-0.000922126684458744,0.146818236517509,-0.288685870258776,0.286841616889859,0.994988975236144
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,35725,0.0391853683080694,0.0613575737552803,-0.08107547625228,0.159446212868419,0.523079893374333
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,35725,0.0754551206349907,0.0454979152015093,-0.0137207931599675,0.164631034429949,0.0972786680866693
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,35725,0.0200807039947499,0.055486481795068,-0.0886728003235834,0.128834208313083,0.717436498756869
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,35725,0.0152194474536725,0.083246346649471,-0.147943391979291,0.178382286886636,0.854941627691979
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,34298,-0.0685968498276082,0.0812853534346078,-0.227916142559439,0.090722442904223,0.398763882738184
LYZL2,Lysozyme-like protein 2,Health and medical history,X29153.Pain or discomfort today,34310,-0.0171676782785842,0.0729952113745215,-0.160238292572646,0.125902936015478,0.814071381927297
LYZL2,Lysozyme-like protein 2,Mental health,X29154.Anxiety or depression today,34310,0.0386745192770691,0.0939190603192616,-0.145406838948684,0.222755877502822,0.680513817121628
LYZL2,Lysozyme-like protein 2,Mental health,X29166.Frequency of confiding in someone close,34158,0.0867445427898945,0.0715030713910902,-0.0534014771366423,0.226890562716431,0.225127084141163
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,34295,0.0213454826784291,0.0110615757076891,-0.000335205708641512,0.0430261710654998,0.0536998575277447
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,34295,0.0080134739290185,0.0113305154618868,-0.0141943363762796,0.0302212842343166,0.479445256449282
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,34295,-0.0101393896931679,0.0141290117125076,-0.0378322526496827,0.017553473263347,0.473018883226789
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,34295,-0.0143888268454502,0.0130903376128068,-0.0400458885665516,0.0112682348756511,0.271735120871444
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,34295,0.00789014878178428,0.0220766947093126,-0.0353801728484685,0.051160470412037,0.720809261159341
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,34295,-0.0233728730350631,0.0107171557196931,-0.0443784982456616,-0.00236724782446464,0.0292375277626233
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,34291,0.00707519420947657,0.0114882850831745,-0.0154418445535455,0.0295922329724986,0.538013333837844
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,34291,0.0095219666136596,0.0176851897933304,-0.0251410053812679,0.0441849386085871,0.590314273279566
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,34291,-0.00749266055533341,0.0257271681269099,-0.0579179100840768,0.04293258897341,0.770883186557884
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,34291,-0.014852870062685,0.0205573394446175,-0.0551452553741354,0.0254395152487653,0.470014523868613
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,34291,0.00269258158625328,0.0334285376387058,-0.06282735218561,0.0682125153581166,0.935805066152642
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,34291,-0.0185635696782148,0.0155270039933129,-0.0489964975051081,0.0118693581486784,0.231921293271714
LYZL2,Lysozyme-like protein 2,Mental health,X29171.Frequency of feeling 'in tune' with people,34209,-0.0538332903189728,0.0915727918392845,-0.233315962323971,0.125649381686025,0.556643147090506
LYZL2,Lysozyme-like protein 2,Mental health,X29172.Freuency of feeling that lacks companionship,34277,0.0137521574852277,0.0834691637146536,-0.149847403395493,0.177351718365949,0.869141534528249
LYZL2,Lysozyme-like protein 2,Mental health,X29173.Frequency of feeling left out,34244,-0.0645089941335358,0.0892887708505626,-0.239514985000639,0.110496996733567,0.470035336204353
LYZL2,Lysozyme-like protein 2,Mental health,X29174.Frequency of feeling isolated from others,34271,-0.0418381846024203,0.0928796548682506,-0.223882308144192,0.140205938939351,0.652401014710411
LYZL2,Lysozyme-like protein 2,Mental health,X29175.Tendency to bounce back quickly after hard times,34306,0.0455741021512533,0.0733147442043312,-0.0981227964892358,0.189271000791742,0.534217790404248
LYZL2,Lysozyme-like protein 2,Mental health,X29176.Ability to make it through stressful events,34306,-0.00539256338137627,0.0696685952413853,-0.141943010054492,0.131157883291739,0.938305927004763
LYZL2,Lysozyme-like protein 2,Mental health,X29177.Quick recovery from stressful events,34306,0.0967733393478461,0.0729422371996571,-0.0461934455634818,0.239740124259174,0.18466327431119
LYZL2,Lysozyme-like protein 2,Mental health,X29178.Hard to snap back when something bad happens,34306,-0.00319811191734922,0.0701869030047715,-0.140764441806701,0.134368217972003,0.963658228187398
LYZL2,Lysozyme-like protein 2,Mental health,X29179.Comes through difficult times with little trouble,34306,0.0965203369278018,0.0725485794307244,-0.0456748787564181,0.238715552612022,0.18343814708404
LYZL2,Lysozyme-like protein 2,Mental health,X29180.Tendency to take a long time to get over setbacks,34306,-0.0541249440639161,0.0709716166086086,-0.193229312616789,0.0849794244889567,0.445720472105246
LYZL2,Lysozyme-like protein 2,Mental health,X29181.General happiness,34283,0.0588343017949757,0.0739448804012892,-0.0860976637915511,0.203766267381502,0.426272181314569
LYZL2,Lysozyme-like protein 2,Mental health,X29182.Belief that own life is meaningful,34201,-0.0656995177408155,0.074630904139219,-0.211976089853685,0.0805770543720537,0.378725062668429
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,34554,-0.0333294209096322,0.0703005756352321,-0.171118549154687,0.104459707335423,0.635448741938764
LYZL2,Lysozyme-like protein 2,Health and medical history,X2946.Father's age,30012,0.0206217117147627,0.0234413970837671,-0.0253234265694208,0.0665668499989462,0.379272935307881
LYZL2,Lysozyme-like protein 2,Health and medical history,X2966.Age high blood pressure diagnosed,35513,-0.00552007966798056,0.0049507775584346,-0.0152236036825124,0.00418344434655125,0.26489605408653
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30000.White blood cell (leukocyte) count,47995,0.0139920780995315,0.00285281790590507,0.00840055500395753,0.0195836011951054,9.43749930809988e-07
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,47996,0.016190358572383,0.00304506461720918,0.010222031922653,0.022158685222113,1.06745038322064e-07
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30020.Haemoglobin concentration,47996,0.0129090117759171,0.00329567388864065,0.00644949095418139,0.0193685325976528,8.9990739367393e-05
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30030.Haematocrit percentage,47996,0.0139921558673327,0.0032022559805702,0.00771573414541514,0.0202685775892503,1.25216517884679e-05
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30040.Mean corpuscular volume,47996,-0.00652800010876689,0.00276767068361835,-0.0119526346486589,-0.00110336556887492,0.0183511176852785
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,47996,-0.00809913984825838,0.00277717360650888,-0.0135424001170158,-0.00265587957950097,0.00354600315937147
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,47996,-0.00393101592636035,0.00271307005331811,-0.00924863323086384,0.00138660137814314,0.147377171891035
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,47996,-0.0010070584984182,0.00279683554212246,-0.00648885616097822,0.00447473916414181,0.718798316481467
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30080.Platelet count,47996,0.0228598220816219,0.00274268112298457,0.0174841670805721,0.0282354770826717,8.28811855749125e-17
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30090.Platelet crit,47996,0.0309691285064264,0.00279357833882996,0.0254937149623197,0.0364445420505331,1.80101701628798e-28
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,47996,0.00632825650706005,0.00260737971156197,0.00121779227239859,0.0114387207417215,0.0152312382150038
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30110.Platelet distribution width,47996,0.00526811914372877,0.00271728554784505,-5.77605300475306e-05,0.0105939988175051,0.0525475486949162
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30120.Lymphocyte count,47964,0.0130470916181837,0.00268410926485063,0.0077862374590765,0.018307945777291,1.1781867678953e-06
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30130.Monocyte count,47964,0.00684752779113492,0.00274913083779351,0.00145923134905964,0.0122358242332102,0.0127542537240872
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30140.Neutrophill count,47964,0.0102316404400469,0.00283061220956956,0.00468364050929057,0.0157796403708032,0.000301553537145764
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30150.Eosinophill count,47964,0.0107707384216596,0.00269676715619989,0.0054850747955078,0.0160564020478114,6.52306847110561e-05
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30160.Basophill count,47964,0.179276472510301,0.0419071541876488,0.0971384503025096,0.261414494718093,1.89560598293882e-05
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30170.Nucleated red blood cell count,47964,-0.177504493844291,0.222674332005623,-0.613946184575312,0.258937196886731,0.425374916950023
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30180.Lymphocyte percentage,47965,0.00245436081278551,0.00267469336814929,-0.0027880381887871,0.00769675981435812,0.358827932777382
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30190.Monocyte percentage,47965,-0.00207996442063044,0.00271913463525152,-0.00740946830572342,0.00324953946446254,0.444319173792769
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30200.Neutrophill percentage,47965,-0.00167812221545297,0.00266047177675073,-0.00689264689788441,0.00353640246697847,0.52820439385902
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30210.Eosinophill percentage,47965,0.00640696218456207,0.00268221905445146,0.00114981283783721,0.0116641115312869,0.0169188557280348
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30220.Basophill percentage,47965,0.00589441943582783,0.0026806438952755,0.000640357401087861,0.0111484814705678,0.027898473062241
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30230.Nucleated red blood cell percentage,47964,-0.177907690892888,0.222599734110444,-0.614203169749358,0.258387787963582,0.424168982379508
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30240.Reticulocyte percentage,47649,0.00905457004878256,0.00289294974675344,0.00338438854514583,0.0147247515524193,0.00175153531846648
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30250.Reticulocyte count,47649,0.012431139676065,0.00294758422536721,0.00665387459434526,0.0182084047577847,2.48314090447754e-05
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30260.Mean reticulocyte volume,47649,-0.00634267038851027,0.00270404177346144,-0.0116425922644947,-0.00104274851252585,0.0190056913537231
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30270.Mean sphered cell volume,47649,-0.00873965487717068,0.00273982066999765,-0.0141097033903661,-0.00336960636397528,0.00142577787677025
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30280.Immature reticulocyte fraction,47649,0.00257272128196111,0.00285711519270945,-0.0030272244957494,0.00817266705967163,0.367886631803319
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,47649,0.00866649478945151,0.00294815784399659,0.00288810541521821,0.0144448841636848,0.00329011098114822
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30300.High light scatter reticulocyte count,47649,0.0115918217835696,0.00298806975621387,0.00573520506139044,0.0174484385057488,0.000105091815493887
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30500.Microalbumin in urine,35873,0.00650716495142329,0.00465274288192251,-0.00261221109714483,0.0156265409999914,0.161989794991251
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,47971,0.000112933109132837,0.00299027631811838,-0.00574800847437919,0.00597387469264487,0.969874032328499
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30520.Potassium in urine,47941,-0.00096589098725688,0.00280160122768776,-0.00645702939352489,0.00452524741901113,0.73027573626837
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30530.Sodium in urine,47923,-0.00527694897039608,0.00294605041554757,-0.0110512077848693,0.000497309844077153,0.0732782476617942
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30600.Albumin,46107,0.0124452266937698,0.00289122522035458,0.00677842526187486,0.0181120281256648,1.68318267877868e-05
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30610.Alkaline phosphatase,47620,0.00950350249999574,0.0028573657207049,0.00390306568741413,0.0151039393125773,0.00088284703197423
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30620.Alanine aminotransferase,47623,0.0101648216325787,0.00302953363408415,0.00422693570977377,0.0161027075553836,0.000794553186826896
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30630.Apolipoprotein A,45985,-0.00412869278097312,0.0031823663676122,-0.010366130861493,0.0021087452995468,0.19452323317572
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30640.Apolipoprotein B,47540,0.00491019615010832,0.00264524876989981,-0.000274491438895295,0.0100948837391119,0.0634364786737643
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30650.Aspartate aminotransferase,47567,0.00675547969361874,0.002894556550888,0.00108214885387826,0.0124288105333592,0.0196139605553281
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30660.Direct bilirubin,44938,-0.00400574976521295,0.00308919249116949,-0.0100605670479051,0.00204906751747925,0.194754117301812
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30670.Urea,47613,0.00571352907899246,0.0028452455250479,0.000136847849898588,0.0112902103080863,0.0446475553444978
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30680.Calcium,46105,0.016414236179268,0.00281458789878625,0.010897643897647,0.0219308284608891,5.58178693592576e-09
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30690.Cholesterol,47627,0.0038163576247103,0.0026708297264725,-0.0014184686391758,0.0090511838885964,0.153048950793685
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30700.Creatinine,47619,0.0109147440612236,0.00321412105049216,0.00461506680225896,0.0172144213201882,0.000685547225210047
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30710.C-reactive protein,47570,0.00290675286948078,0.00301686193542301,-0.00300629652394832,0.00881980226290988,0.335308279600733
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30720.Cystatin C,47633,0.0129000859308339,0.00314385232154984,0.00673813538059619,0.0190620364810716,4.09095831066131e-05
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30730.Gamma glutamyltransferase,47621,0.00789876118616041,0.00305929317382269,0.00190254656546794,0.0138949758068529,0.00983371108481908
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30740.Glucose,46091,0.00164880808387068,0.00288823471846047,-0.00401213196431185,0.00730974813205321,0.568095000813852
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),47624,0.00873759347034571,0.00294815366504244,0.00295921228686253,0.0145159746538289,0.00304302631313197
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30760.HDL cholesterol,46098,-0.00949830473890215,0.0032674460066226,-0.0159024989118824,-0.00309411056592185,0.00365444796190621
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30770.IGF-1,47521,0.00472432142060579,0.00279904576003829,-0.000761808269069251,0.0102104511102808,0.0914603322535023
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30780.LDL direct,47583,0.00377670639179078,0.00261669010372838,-0.00135200621151685,0.00890541899509841,0.148948971718301
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30790.Lipoprotein A,43889,-0.00149193086892424,0.00298756829288584,-0.00734756472298048,0.004363702985132,0.617519414538041
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30810.Phosphate,46075,0.0106277264079834,0.00300863560579845,0.00473080062061842,0.0165246521953483,0.000412893574389411
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30830.SHBG,45953,-0.0145080417678393,0.00349342484283061,-0.0213551544597872,-0.00766092907589127,3.29831856058584e-05
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30840.Total bilirubin,47550,-0.0040411420306447,0.00294829579686959,-0.0098198017925091,0.00173751773121971,0.170494459270862
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30850.Testosterone,45439,0.00652561272221352,0.00461210763877144,-0.0025141182497785,0.0155653436942055,0.157120697072479
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30860.Total protein,46092,0.0159612412321947,0.00281708781592031,0.0104397491129909,0.0214827333513985,1.48667873581615e-08
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30870.Triglycerides,47615,0.0257805059722531,0.00304474024749167,0.0198128150871694,0.0317481968573368,2.69932808147641e-17
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30880.Urate,47597,0.0110256750340534,0.00332473897465456,0.00450918664373044,0.0175421634243763,0.000914098134139149
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30890.Vitamin D,46687,0.00113995265032054,0.00309322869036609,-0.00492277558279699,0.00720268088343807,0.712481315064613
LYZL2,Lysozyme-like protein 2,Physical measures,X3137.Number of measurements made,46432,-0.0359798737007086,0.0481453132770574,-0.130344687723741,0.0583849403223239,0.45488164234541
LYZL2,Lysozyme-like protein 2,Physical measures,X3143.Ankle spacing width,40093,-0.0123964344903507,0.00466460991387828,-0.0215390699215522,-0.00325379905914931,0.00788256999672307
LYZL2,Lysozyme-like protein 2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",40093,-0.00251623358465977,0.00362836739737833,-0.0096278336835213,0.00459536651420177,0.488017382846908
LYZL2,Lysozyme-like protein 2,Physical measures,X3146.Speed of sound through heel,40093,-0.00137945897978181,0.00348620828072759,-0.00821242721000788,0.00545350925044427,0.692341219151663
LYZL2,Lysozyme-like protein 2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",40093,-0.0017966144591215,0.00352807040126267,-0.00871163244559632,0.00511840352735332,0.610598313206812
LYZL2,Lysozyme-like protein 2,Physical measures,X3148.Heel bone mineral density (BMD),40083,-0.00185013225473689,0.00353248412158317,-0.00877380113303991,0.00507353662356614,0.600464334482152
LYZL2,Lysozyme-like protein 2,Health and medical history,X3526.Mother's age at death,45229,-0.00361276268031489,0.00280756600595533,-0.00911559205198734,0.00189006669135756,0.198184229166682
LYZL2,Lysozyme-like protein 2,Health and medical history,X3581.Age at menopause (last menstrual period),37020,-0.0024553386858364,0.00385505972541303,-0.0100112557476459,0.00510057837597313,0.52419996743708
LYZL2,Lysozyme-like protein 2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",32219,-0.00289465460293255,0.00604214918929205,-0.014737267013945,0.00894795780807986,0.631918492147035
LYZL2,Lysozyme-like protein 2,Physical measures,X4100.Ankle spacing width (left),35608,0.000724738057037578,0.00638606952690217,-0.0117919582156907,0.0132414343297658,0.909647749614023
LYZL2,Lysozyme-like protein 2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),35606,0.000473061865181468,0.00499110394593682,-0.0093095018688547,0.0102556255992176,0.924491733671231
LYZL2,Lysozyme-like protein 2,Physical measures,X4103.Speed of sound through heel (left),35608,0.000929110285701156,0.00477764903803077,-0.00843508182883916,0.0102933024002415,0.845813898983174
LYZL2,Lysozyme-like protein 2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",35608,0.000617104328801795,0.00484064868502669,-0.00887056709385051,0.0101047757514541,0.898561484163475
LYZL2,Lysozyme-like protein 2,Physical measures,X4105.Heel bone mineral density (BMD) (left),35605,0.0011156111358872,0.00483480536592217,-0.00836060738132026,0.0105918296530947,0.817519636398803
LYZL2,Lysozyme-like protein 2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",35608,0.00061634353156366,0.00484062896419889,-0.00887128923826616,0.0101039763013935,0.898685457255104
LYZL2,Lysozyme-like protein 2,Physical measures,X4119.Ankle spacing width (right),35605,0.00109161552068983,0.0063291580707458,-0.0113135342979719,0.0134967653393516,0.86307030562205
LYZL2,Lysozyme-like protein 2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),35604,0.00167156570127151,0.00496978688354564,-0.00806921659047793,0.011412347993021,0.736621314699823
LYZL2,Lysozyme-like protein 2,Physical measures,X4122.Speed of sound through heel (right),35605,0.00287213992050214,0.00475065122514392,-0.00643913648077994,0.0121834163217842,0.545480725011829
LYZL2,Lysozyme-like protein 2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",35605,0.00262342982469805,0.00481583606345463,-0.00681560885967301,0.0120624685090691,0.585943972177818
LYZL2,Lysozyme-like protein 2,Physical measures,X4124.Heel bone mineral density (BMD) (right),35601,0.00295053375717214,0.00481286452667521,-0.00648268071511127,0.0123837482294555,0.539864056256345
LYZL2,Lysozyme-like protein 2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",35605,0.00262258486666414,0.00481582154400658,-0.00681642535958875,0.012061595092917,0.586063529516393
LYZL2,Lysozyme-like protein 2,Physical measures,X4194.Pulse rate,35905,-0.00338914034765643,0.00455173905420864,-0.0123105488939054,0.00553226819859251,0.456550872640613
LYZL2,Lysozyme-like protein 2,Physical measures,X4195.Pulse wave reflection index,35905,-0.00402060314087851,0.00491005699859994,-0.0136443148581344,0.00560310857637738,0.412900730915037
LYZL2,Lysozyme-like protein 2,Physical measures,X4196.Pulse wave peak to peak time,35901,0.00529117553705474,0.00449757167543882,-0.00352406494680536,0.0141064160209148,0.239456202151592
LYZL2,Lysozyme-like protein 2,Physical measures,X4198.Position of the pulse wave peak,35905,-0.00381481812317256,0.00478700681619133,-0.0131973514829076,0.00556771523656245,0.425530945881926
LYZL2,Lysozyme-like protein 2,Physical measures,X4199.Position of pulse wave notch,35905,-0.00281295249717325,0.00456341442906425,-0.0117572447781392,0.00613133978379268,0.537642230241567
LYZL2,Lysozyme-like protein 2,Physical measures,X4200.Position of the shoulder on the pulse waveform,35905,-0.00523900266288548,0.00471146770734439,-0.0144734793692805,0.00399547404350953,0.266191619343723
LYZL2,Lysozyme-like protein 2,Physical measures,X4269.Number of triplets attempted (left),35750,-0.333677924295946,0.163412048629924,-0.653965539610598,-0.0133903089812946,0.0411973078153682
LYZL2,Lysozyme-like protein 2,Physical measures,X4270.Volume level set by participant (left),35678,-0.0329867990564444,0.0622668243522921,-0.155029774786937,0.0890561766740481,0.596292856111147
LYZL2,Lysozyme-like protein 2,Physical measures,X4276.Number of triplets attempted (right),35745,-0.178480575116318,0.170096155676409,-0.511869040242079,0.154907890009444,0.294082424155386
LYZL2,Lysozyme-like protein 2,Physical measures,X4277.Volume level set by participant (right),35670,-0.0952077538514877,0.0619023879481174,-0.216536434229798,0.0261209265268224,0.124090062347561
LYZL2,Lysozyme-like protein 2,Cognitive function,X4288.Time to answer,35908,0.00161329900372448,0.00544574277468543,-0.00906035683465896,0.0122869548421079,0.76704865141349
LYZL2,Lysozyme-like protein 2,Cognitive function,X4290.Duration screen displayed,35908,-0.00235359628104296,0.00505563419468878,-0.012262639302633,0.00755544674054704,0.641560417513067
LYZL2,Lysozyme-like protein 2,Physical measures,X46.Hand grip strength (left),48484,-0.00448411339979942,0.00387654453416104,-0.012082140686755,0.00311391388715622,0.247397219732682
LYZL2,Lysozyme-like protein 2,Physical measures,X47.Hand grip strength (right),48504,-0.00153344442359372,0.00384872890498288,-0.00907695307736016,0.00601006423017272,0.690318540264995
LYZL2,Lysozyme-like protein 2,Physical measures,X48.Waist circumference,48561,0.0126086599684851,0.00586426801261869,0.00111469466375242,0.0241026252732177,0.0315610331072444
LYZL2,Lysozyme-like protein 2,Health and medical history,X4803.Tinnitus,35821,-0.0626545429096998,0.069631727395917,-0.199132728605697,0.0738236427862974,0.368260056463836
LYZL2,Lysozyme-like protein 2,Working and living environment,X4825.Noisy workplace,35895,-0.0234671529177935,0.0814024127291963,-0.183015881867018,0.136081576031431,0.773136958342297
LYZL2,Lysozyme-like protein 2,Working and living environment,X4836.Loud music exposure frequency,35853,0.12653297730334,0.128267963689958,-0.124872231528978,0.377938186135658,0.323936549466619
LYZL2,Lysozyme-like protein 2,Physical measures,X49.Hip circumference,48556,-0.0209257873916866,0.00475918211661599,-0.0302537843402539,-0.0115977904431193,1.10377930645751e-05
LYZL2,Lysozyme-like protein 2,Physical measures,X50.Standing height,48545,-0.0132929510267426,0.00376431812306719,-0.0206710145479543,-0.00591488750553086,0.000414477971176655
LYZL2,Lysozyme-like protein 2,Health and medical history,X5057.Number of older siblings,34875,-0.0117498652026956,0.0656236179381321,-0.140372156361434,0.116872425956043,0.857905349352831
LYZL2,Lysozyme-like protein 2,Physical measures,X51.Seated height,48471,-0.000711878167682473,0.00352959203988144,-0.0076298785658501,0.00620612223048515,0.840162372025521
LYZL2,Lysozyme-like protein 2,Eye measures,X5181.Ever had eye surgery,33720,-0.261081905163094,0.151521158044152,-0.558063374929632,0.0358995646034439,0.0849437908396298
LYZL2,Lysozyme-like protein 2,Eye measures,X5186.Duration visual-acuity screen displayed (right),33707,-0.0107840672713058,0.00534756612741212,-0.0212652968810335,-0.000302837661578011,0.0437931617966406
LYZL2,Lysozyme-like protein 2,Eye measures,X5188.Duration visual-acuity screen displayed (left),33706,-0.0117932601731687,0.00552105884244451,-0.02261453550436,-0.0009719848419775,0.0327289700602537
LYZL2,Lysozyme-like protein 2,Eye measures,X5190.Duration at which refractometer first shown (right),33647,-0.0104769408363061,0.00566451592494373,-0.0215793920491958,0.000625510376583613,0.064441206134466
LYZL2,Lysozyme-like protein 2,Eye measures,X5193.Duration at which refractometer first shown (left),33645,-0.00815601588702632,0.00572447153104634,-0.0193759800878771,0.0030639483138245,0.154295797966548
LYZL2,Lysozyme-like protein 2,Eye measures,"X5199.logMAR, initial (right)",33692,0.0808988705201445,0.0816120315887647,-0.0790607113938343,0.240858452434123,0.321611205262097
LYZL2,Lysozyme-like protein 2,Eye measures,X5200.Final number of letters displayed (right),33692,0.675397528309725,0.565972139658425,-0.433907865420788,1.78470292204024,0.232798976910591
LYZL2,Lysozyme-like protein 2,Eye measures,"X5201.logMAR, final (right)",33640,-0.00246038362477057,0.00596426824062432,-0.0141503493763942,0.0092295821268531,0.679977761403009
LYZL2,Lysozyme-like protein 2,Eye measures,X5202.Number of rounds to result (right),33692,0.0971285908236266,0.0739132078482524,-0.047741296558948,0.241998478206201,0.188883168626423
LYZL2,Lysozyme-like protein 2,Eye measures,"X5206.logMAR, initial (left)",33687,0.0268988643216529,0.0799833130136033,-0.12986842918501,0.183666157828315,0.73665586970551
LYZL2,Lysozyme-like protein 2,Eye measures,X5207.Final number of letters displayed (left),33687,-0.040845536754533,0.419584150671024,-0.86323047206974,0.781539398560674,0.922454649618455
LYZL2,Lysozyme-like protein 2,Eye measures,"X5208.logMAR, final (left)",33636,-0.00491194128914152,0.00587022747247294,-0.0164175871351885,0.00659370455690544,0.402775394979671
LYZL2,Lysozyme-like protein 2,Eye measures,X5209.Number of rounds to result (left),33685,0.0510207892271434,0.0744818480910709,-0.0949636330313555,0.197005211485642,0.493373231955235
LYZL2,Lysozyme-like protein 2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",33481,0.0064874313153421,0.00557548991909816,-0.0044405289260903,0.0174153915567745,0.244666088477214
LYZL2,Lysozyme-like protein 2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",33481,0.007194889592737,0.00561137448732144,-0.00380340440241302,0.018193183587887,0.199842750159198
LYZL2,Lysozyme-like protein 2,Eye measures,X5256.Corneal hysteresis (right),33481,-0.0026350974818253,0.00561792729700053,-0.0136462349839463,0.00837604002029574,0.639056644141452
LYZL2,Lysozyme-like protein 2,Eye measures,X5257.Corneal resistance factor (right),33481,0.00234651868561509,0.00566024643113458,-0.00874756431940869,0.0134406016906389,0.678483881893131
LYZL2,Lysozyme-like protein 2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",33473,0.00997634390570345,0.00555237728143322,-0.000906315565905653,0.0208590033773126,0.0724426684641062
LYZL2,Lysozyme-like protein 2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",33473,0.00536156027926354,0.00557791943664673,-0.00557116181656406,0.0162942823750911,0.336500149503083
LYZL2,Lysozyme-like protein 2,Eye measures,X5264.Corneal hysteresis (left),33473,-0.00829876045650741,0.00566828765205157,-0.0194086042545285,0.00281108334151367,0.143248735927261
LYZL2,Lysozyme-like protein 2,Eye measures,X5265.Corneal resistance factor (left),33473,-0.003445120519599,0.00567866991738735,-0.0145753135576782,0.00768507251848022,0.544097229939886
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,33774,0.29899646899122,0.367497255361859,-0.421298151518025,1.01929108950046,0.415915346888318
LYZL2,Lysozyme-like protein 2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",48516,-0.0068818454372168,0.0142988192151015,-0.0349075310988158,0.0211438402243822,0.630317506597541
LYZL2,Lysozyme-like protein 2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",48516,-0.0149433999544108,0.0151792850941445,-0.0446947987389339,0.0148079988301123,0.324901685562656
LYZL2,Lysozyme-like protein 2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",48516,0.0244166072491949,0.0396129551067657,-0.0532247847600659,0.102057999258456,0.537651445070753
LYZL2,Lysozyme-like protein 2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",48516,-0.0101189496609271,0.00613794421513864,-0.0221493203225988,0.00191142100074467,0.0992480430822893
LYZL2,Lysozyme-like protein 2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",48516,0.00980013956301463,0.00578254101119906,-0.00153364081893553,0.0211339199449648,0.0901331222236252
LYZL2,Lysozyme-like protein 2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",36788,8.67059708507494e-05,0.00839227095678242,-0.0163621451044428,0.0165355570461443,0.991756957384619
LYZL2,Lysozyme-like protein 2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",36788,-0.00162424777802709,0.0178538357723631,-0.0366177658918588,0.0333692703358046,0.927515074660869
LYZL2,Lysozyme-like protein 2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",36788,-0.000783459322377836,0.0217025881376248,-0.0433205320721224,0.0417536134273667,0.971203722143657
LYZL2,Lysozyme-like protein 2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",36788,0.0261477740109931,0.0119526117855732,0.00272065491126963,0.0495748931107166,0.0287276657443194
LYZL2,Lysozyme-like protein 2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,48575,-0.00929749252172342,0.0118633835578609,-0.0325497242951307,0.0139547392516839,0.433217882291583
LYZL2,Lysozyme-like protein 2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,48575,-0.00929749252172342,0.0118633835578609,-0.0325497242951307,0.0139547392516839,0.433217882291583
LYZL2,Lysozyme-like protein 2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),48575,0.00690452997858221,0.00959057227059767,-0.0118929916717892,0.0257020516289536,0.471577465409439
LYZL2,Lysozyme-like protein 2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',48575,0.015084656566765,0.0163416348239568,-0.0169449476881904,0.0471142608217204,0.355976360628554
LYZL2,Lysozyme-like protein 2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),48575,-0.00475389897016751,0.0414816194386354,-0.0860578730698928,0.0765500751295578,0.908761353143704
LYZL2,Lysozyme-like protein 2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),48575,-0.00411367230231133,0.0271862422585096,-0.0573987071289902,0.0491713625243676,0.879729216702325
LYZL2,Lysozyme-like protein 2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,48575,-0.0417159837470717,0.0435145672435856,-0.1270045355445,0.0435725680503561,0.337738439058912
LYZL2,Lysozyme-like protein 2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,48516,0.00482921251016215,0.00881688461015964,-0.0124518813257507,0.0221103063460751,0.583888286296673
LYZL2,Lysozyme-like protein 2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,48516,-0.00197504772894401,0.0148294242545194,-0.0310407192678021,0.0270906238099141,0.894048947829911
LYZL2,Lysozyme-like protein 2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,48516,0.0204874575348009,0.00878297360542956,0.00327282926815891,0.0377020858014428,0.019677607338716
LYZL2,Lysozyme-like protein 2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,48516,0.0122630570718761,0.0123968356307117,-0.0120347407643189,0.0365608549080711,0.322573452878335
LYZL2,Lysozyme-like protein 2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,48516,0.0384115641904123,0.015036480937807,0.00894006155231067,0.0678830668285139,0.0106398664491429
LYZL2,Lysozyme-like protein 2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,48516,-0.00662644550612317,0.00593400632421678,-0.0182570979015881,0.00500420688934172,0.264140782119326
LYZL2,Lysozyme-like protein 2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,37211,-0.0109469864541964,0.0137610149214159,-0.0379185757001715,0.0160246027917787,0.426342076035962
LYZL2,Lysozyme-like protein 2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,37211,0.00612757388705101,0.011784802466433,-0.0169706389471577,0.0292257867212597,0.603108886822645
LYZL2,Lysozyme-like protein 2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,37211,0.00698547088859026,0.0169302940125401,-0.0261979053759883,0.0401688471531689,0.679909367598681
LYZL2,Lysozyme-like protein 2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,37211,0.00576044415993055,0.0132364065292528,-0.020182912637405,0.0317038009572661,0.663431168900106
LYZL2,Lysozyme-like protein 2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,48506,-0.00268156355223269,0.0202256720712001,-0.0423238808117848,0.0369607537073194,0.894525213171895
LYZL2,Lysozyme-like protein 2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,48506,-0.000328708105945667,0.0322486306004839,-0.063536024082894,0.0628786078710027,0.991867462862347
LYZL2,Lysozyme-like protein 2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,48506,0.0119904599188705,0.0476612786107508,-0.0814256461582012,0.105406565995942,0.801371065002359
LYZL2,Lysozyme-like protein 2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,48506,-0.0490718745964158,0.0528947946602966,-0.152745672130597,0.0546019229377655,0.353561328787939
LYZL2,Lysozyme-like protein 2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,48506,-0.018106615075031,0.0169873122243087,-0.0514017470346761,0.0151885168846141,0.28648645988097
LYZL2,Lysozyme-like protein 2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,48506,0.00433765301663727,0.0233989099274103,-0.0415242104410868,0.0501995164743614,0.852934178039888
LYZL2,Lysozyme-like protein 2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,48506,-0.00821778846491901,0.0122837176565835,-0.0322938750718227,0.0158582981419847,0.503504443272294
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",34930,0.0101781343214583,0.016404829307885,-0.0219753311219963,0.0423315997649129,0.534995921871568
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",34930,-0.0129981769977231,0.0170305463817853,-0.0463780479060223,0.020381693910576,0.44535927113966
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",34930,-0.0185339016538901,0.0243328921479885,-0.0662263702639476,0.0291585669561674,0.446281731961668
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",34930,0.0165761018553969,0.0100041368745067,-0.00303200641863631,0.03618421012943,0.0975893827347028
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",38670,0.00429331459840659,0.00780342211703852,-0.0110013927509889,0.0195880219478021,0.582206442947544
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",38670,0.0107391916426425,0.00917585054298403,-0.00724547542160617,0.0287238587068912,0.241879280736051
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",38670,-0.0059413218024077,0.00764306569446386,-0.0209217305635569,0.00903908695874147,0.436972890494127
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",38670,0.0218457721847006,0.0175954550803069,-0.0126413197727009,0.056332864142102,0.214430538948747
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",38670,-0.00205592116598581,0.00979897627867059,-0.0212619146721802,0.0171500723402085,0.833820641460598
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",38670,-0.000968130737417066,0.0141453080036799,-0.0286929344246297,0.0267566729497956,0.945435369996086
LYZL2,Lysozyme-like protein 2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,48516,0.0154182354713872,0.016459639900415,-0.0168426587334263,0.0476791296762006,0.348909262285357
LYZL2,Lysozyme-like protein 2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,48516,0.00770108043199395,0.0124822096231178,-0.0167640504293169,0.0321662112933048,0.537265399788844
LYZL2,Lysozyme-like protein 2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,48516,-0.00834040218318484,0.0333158428833325,-0.0736394542345165,0.0569586498681468,0.802324439416016
LYZL2,Lysozyme-like protein 2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,48516,-0.0124681707069021,0.0116732679322415,-0.0353477758540954,0.0104114344402912,0.285490557070183
LYZL2,Lysozyme-like protein 2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,48516,0.0238592821131656,0.0135245583018444,-0.00264885215844941,0.0503674163847806,0.0777233663005132
LYZL2,Lysozyme-like protein 2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),48516,0.00666125656524972,0.0165252723740702,-0.0257282772879279,0.0390507904184274,0.686882714277224
LYZL2,Lysozyme-like protein 2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,48516,0.00154055167550043,0.00554230792049005,-0.00932237184866007,0.0124034751996609,0.781044408987657
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,33965,0.00787994493367969,0.014307988253355,-0.020163712042896,0.0359236019102554,0.581839450494393
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,33965,-0.00727089109165103,0.0178622709721617,-0.042280942197088,0.0277391600137859,0.683987314421839
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,33965,1.04466016656442e-05,0.0123609353131034,-0.024216986612017,0.0242378798153483,0.999325718942904
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,33965,0.00200090342962713,0.0115874413340066,-0.0207104815850258,0.02471228844428,0.862911369701198
LYZL2,Lysozyme-like protein 2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,48593,-0.00229162667038911,0.00736355890907488,-0.0167242021321759,0.0121409487913977,0.755642931498592
LYZL2,Lysozyme-like protein 2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,48593,-0.00435744964024267,0.0206542924445169,-0.0448398628314958,0.0361249635510105,0.832912384577539
LYZL2,Lysozyme-like protein 2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,48593,-0.000796308356221622,0.0061759423276169,-0.0129011553183507,0.0113085386059075,0.897408723137265
LYZL2,Lysozyme-like protein 2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,48593,-0.0128915162973703,0.00594057150772109,-0.0245350364525037,-0.00124799614223702,0.0300128689851034
LYZL2,Lysozyme-like protein 2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,48593,0.0105453752703963,0.0101300754956996,-0.00930957270117485,0.0304003232419675,0.297890048331085
LYZL2,Lysozyme-like protein 2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,48593,-0.00852374417890808,0.00757349335667256,-0.0233677911579863,0.00632030280017014,0.260403588998959
LYZL2,Lysozyme-like protein 2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,48593,-0.00317086878876731,0.00619600889943444,-0.0153150462316588,0.00897330865412419,0.608824895493297
LYZL2,Lysozyme-like protein 2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,48593,0.0102552015799135,0.0191387357376799,-0.0272567204659391,0.0477671236257661,0.592078837999256
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,42999,-0.0140723115772129,0.00648053220026194,-0.0267741546897263,-0.00137046846469948,0.0299122819871881
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,42999,0.00428218436027787,0.00674166932303876,-0.00893148751287809,0.0174958562334338,0.525320504665785
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,42999,0.00217746109970928,0.00712756358551161,-0.0117925635278935,0.016147485727312,0.759990999131564
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,42999,0.0024663557765994,0.00966209443881489,-0.0164713493234778,0.0214040608766766,0.798525331470573
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,42999,0.00149164537567983,0.00649932096892542,-0.011247023723414,0.0142303144747736,0.8184775969884
LYZL2,Lysozyme-like protein 2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,48409,0.00184543307193541,0.00647593350645602,-0.0108473966007184,0.0145382627445892,0.775671817818771
LYZL2,Lysozyme-like protein 2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,48409,-0.0022937171846177,0.00526639511486694,-0.0126158516097569,0.00802841724052151,0.663176580847092
LYZL2,Lysozyme-like protein 2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,48409,-0.00686083463508713,0.00545480747510935,-0.0175522572863015,0.0038305880161272,0.208494116946009
LYZL2,Lysozyme-like protein 2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,48409,0.00717867769811014,0.0119085286518458,-0.0161620384595075,0.0305193938557278,0.546636758242884
LYZL2,Lysozyme-like protein 2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),48424,0.00706019813878202,0.00587038087236559,-0.00444574837105453,0.0185661446486186,0.229114425428638
LYZL2,Lysozyme-like protein 2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,48424,0.00900462545372756,0.0115485511166226,-0.0136305347348527,0.0316397856423078,0.435565851787693
LYZL2,Lysozyme-like protein 2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),48516,-0.00329488309576715,0.00535247748094773,-0.0137857389584247,0.00719597276689041,0.538178387393083
LYZL2,Lysozyme-like protein 2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,48516,7.88854195380847e-05,0.00611362434007703,-0.0119038182870129,0.0120615891260891,0.989705141520913
LYZL2,Lysozyme-like protein 2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,48516,0.0073029779038071,0.00926583544077631,-0.0108580595601145,0.0254640153677287,0.43061171631416
LYZL2,Lysozyme-like protein 2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,48516,0.00212779177224731,0.012891936654611,-0.0231404040707902,0.0273959876152848,0.868907719889261
LYZL2,Lysozyme-like protein 2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,48516,0.00298110271010524,0.0163933668361224,-0.0291498962886946,0.0351121017089051,0.855703838321434
LYZL2,Lysozyme-like protein 2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,48516,-0.00822580377927913,0.0151289723287941,-0.0378785895437156,0.0214269819851573,0.586645947521775
LYZL2,Lysozyme-like protein 2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",40093,-0.00179655046550863,0.00352805132083494,-0.0087115310543451,0.00511843012332785,0.610609095207457
LYZL2,Lysozyme-like protein 2,Physical activities,X864.Number of days or week walked 10+ minutes,48119,-0.00243113508658479,0.0373693206905596,-0.0756750036400815,0.0708127334669119,0.94812932150939
LYZL2,Lysozyme-like protein 2,Physical activities,X874.Duration of walks,45544,-0.00373879451891153,0.00293191591400636,-0.00948534971036399,0.00200776067254093,0.202254728543268
LYZL2,Lysozyme-like protein 2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,47311,-0.0195508973066992,0.0359161890562018,-0.0899466278568548,0.0508448332434563,0.586208883910493
LYZL2,Lysozyme-like protein 2,Physical activities,X894.Duration of moderate activity,43247,0.00114432751124287,0.0444872258805302,-0.0860506352145963,0.088339290237082,0.979478955803057
LYZL2,Lysozyme-like protein 2,Physical activities,X90087.No-wear time bias adjusted average acceleration,32797,-0.00899921773177548,0.00695009961100547,-0.0226214129693462,0.00462297750579523,0.195460843416585
LYZL2,Lysozyme-like protein 2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,47246,-0.0721878948197366,0.0379023247923483,-0.146476451412739,0.00210066177326609,0.0568509668963231
LYZL2,Lysozyme-like protein 2,Physical activities,X914.Duration of vigorous activity,38633,-0.00460424050041059,0.00362117529941791,-0.0117017440872697,0.00249326308644851,0.203590393078222
